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General Introduction 
Clostridium perfringens 
The Gram-positive anaerobic, spore-forming bacteria, Clostridium spp., are 
commonly found in soil, marine, fresh water sediments, and gastrointestinal tracts of animals 
as well as humans. Members of these pathogenic bacteria are involved in a variety of diseases 
including gas gangrene, food poisoning, antibiotic-associated diarrhea, pseudomembranous 
colitis, and enterotoxemia of humans, domestic animals, and wildlife (Songer, 1996; Petit et 
al, 1999; Stiles et al, 2014; Hassen et al, 2015). Clostridium perfringens have been classified 
into five toxin types (A-E) on the basis of the production of four major lethal toxins (, , , 
and ). Most of the virulent genes from C. perfringens have been characterized (Table 1). In 
addition, the C. perfringens enterotoxin (CPE) encoded by cpe is well known and has been 
studied worldwide. This CPE causes diarrhea by forming pores in enterocytes and subsequent 
leakage of water and ions.  
 
Table 1: Classification of C. perfringens major toxins. Modified from Songer, 1996; Petit et al, 
1999. 
Toxin Gene 
name 
Mode of action Biological activity 
 plc Phospholipase C/ 
sphingomyelinase 
Cytolytic, hemolytic, dermonecrotic, lethal 
1 cpb1 Pore-forming activity? 
Cell membrane disruption? 
Cytolytic, dermonecrotic, lethal 
Hemorrhagic necrosis of intestinal mucosa 
2 cpb2 Pore-forming activity? 
Cell membrane disruption? 
Cytolytic, lethal 
Hemorrhagic necrosis of intestinal mucosa 
 etx Alteration of cell 
membrane permeability 
(pore-forming activity?) 
Edema in various organs: liver, kidney, and 
central nervous system 
Dermonecrotic, lethal 
 iap 
ibp 
ADP-ribosylation of actin 
(Ia) 
Disruption of actin cytoskeleton, disruption of 
cell barrier integrity 
Dermonecrotic, lethal 
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The classic method of identification has been the mouse lethality test developed in 
1931. An alternative method characterizes the necrotic and erythematous lesions caused by 
an intradermal injection of C. perfringens culture supernatants into a guinea pig. Each type of 
toxin causes a specific symptom (Table 2); hence, the correct identification of causative 
pathovars is critical for epidemiological studies and development of effective preventive 
procedures, including vaccines (Petit et al, 1999). 
 
Table 2: Diseases associated C. perfringens. Modified from Songer, 1996; Petit et al, 1999. 
Toxin 
type 
Major 
toxin(s) 
Associated pathology 
Human Animals 
A  Gangrene 
Gastrointestinal diseases (food 
poisoning, antibiotic-associated 
diarrhea, sporadic diarrhea) 
Myonecrosis, food poisoning, 
necrotic enteritis (fowl) 
Enteroxemia (cattle, lambs) 
Necrotizing enterocolitis (piglets) 
Diarrhea (foals, pigs) 
Necrotic enteritis (fowl) 
B , ,   Dysentery (newborn lambs) 
Chronic enteritis (older lambs) 
Hemorrhagic enteritis (neonatal 
calves and foals) 
Hemorrhagic enterotoxemia (sheep) 
C ,  Necrotic enteritis Necrotic enteritis (fowl) 
Hemorrhagic or necrotic 
enterotoxemia (neonatal pigs, lambs, 
calves, goats, and foals) 
Acute enterotoxemia (sheep) 
D ,   Enterotoxemia (lambs, calves) 
Enterocolitis (neonatal and adult 
goats) 
E ,   Enterotoxemia (calves, lambs) 
Enteritis (rabbits) 
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Most of the C. perfringens toxins act on the cell membrane (Figure 1). Alpha-toxin is 
a membrane-damaging toxin and possesses phospholipase C/ sphingomyelinase activities 
(Figure 1A). The 1-toxin and 2-toxin might be membrane-damaging toxins. A complex of 
-toxin and membrane protein alters the membrane permeability (Figure 1B). The -toxin, -
toxin, and C. perfringens enterotoxin (CPE) belong to groups of pore-forming toxins. These 
groups recognize specific membrane receptors (Figure 1C, 1D).  
 
 
Figure 1: Schematic representation of the targets and modes of action of the C. perfringens toxins. A) 
-Toxin is a membrane-damaging toxin and causes dissociation of the phospholipid bilayer as a 
consequence. B) -Toxin forms a large complex with a membrane protein (green oval) and alters the 
membrane permeability. C) θ-Toxin recognizes cholesterol (orange oval) and forms a pore. D) CPE 
recognizes a protein receptor (brown oval) and forms a large complex with another membrane protein 
(purple oval). This pore-forming by θ-toxin and CPE-complex causes leakage of small molecules such as, 
water, ions, nucleic acids (NA) and amino acids (AA). Modified from Petit et al., (1999). 
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In the case of -toxin, this binary toxin acts intracellularly. The binding component 
(Ib) mediates internalization of the enzymatic component (Ia) into the target cell, as will be 
described in the next section. After entering the cell, Ia possesses ADP-ribosylation to actin. 
The consequence of ADP-ribosylation of actin monomers by Ia is disruption of the actin 
cytoskeleton. Moreover, C. perfringens also produces various hydrolytic enzymes, which act 
as additional virulence factors in gangrenous lesions by favoring degradation of extracellular 
and lysed cell substrates and providing nutrients for C. perfringens growth (Petit et al, 1999). 
 
C. perfringens Iota toxin  
Iota toxin is one of the major lethal and dermonecrotic toxins of C. perfringens type E. 
Iota toxin is classified as a member of the clostridial binary toxin group. Iota toxin consists of 
two unlinked proteins: an enzymatic component (Ia) and a binding component (Ib) (Sakurai 
and Kobayashi, 1995). Each component is nontoxic; however, a mixture of Ia and Ib are 
cytotoxic to various cultured cells. Once it binds to the lipolysis-stimulated lipoprotein 
receptor (LSR) on target cells, Ib forms a heptamer and assists translocation of Ia into cytosol 
(Papatheodorou et al., 2011). Then Ia–Ib is transported to the endosome where acidification 
promotes cytosolic entry of Ia. After internalization, Ia ADP-ribosylates globular skeletal 
muscle -actin and non-muscle /-actin at Arg-177 (Perelle et al., 1993; Marvaud et al., 
2002; Sakurai et al., 2009; Papatheodorou et al., 2011).  
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Figure 2: Catalytic mechanism of the ADP-ribosylation reaction. Step 1: Cleavage of the nicotinamide 
moiety and production of oxocarbenium cation. Step 2: deprotonation of Arg177 of actin and bond 
formation between the NC1 of N-ribose and guanidyl nitrogen of Arg177. Source: Tsurumura et al., 2013.  
 
Based on several complex structures of Ia–actin, the mechanism of actin–ADP-
ribosylation is proposed (Tsurumura et al., 2013) in Figure 2. The strain-alleviation model 
consists of two main steps and two conformations of the oxocarbenium cation intermediate. 
The ADP moiety of NAD
+
 is gripped between Gln300-Arg352-Arg296 on one side and 
Asn335-Arg295 on another side of Ia. Once the nicotinamide moiety is cleaved at the first 
step, the oxocarbenium cation intermediate is formed, which in turn causes strain on the ADP 
moiety itself. Then, the conformation of the oxocarbenium cation intermediate changes and 
closes to the protonated Arg177
A
 (*amino acid residues of actin are shown in superscript) 
followed by bond formation between the NC1 of N-ribose and the guanidyl nitrogen of 
Arg177
A
. At this second step, the strain is relieved, which is termed alleviation (Tsurumura et 
al., 2013). If there is no actin, Ia shows NAD glycohydrolase activity, which suggests that the 
oxycarbenium ion is attacked by a water molecule instead of Arg177
A
. 
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Monomeric globular actin (G-actin) has a pivotal role in filamentous actin (F-actin) 
formation essential for cytoskeleton development and cellular processes (Aktories et al., 
2011). Actin polymerization proceeds until equilibrium is established between monomeric 
and filamentous actin (Aktories et al., 2011; Stiles et al., 2011). During polymerization, ATP-
bound G-actin preferentially associates with the fast-growing end (barbed end). After 
reaching equilibrium, actin monomers associate with the barbed end, and an identical number 
dissociates preferentially from the opposite end (pointed end).  
The ADP-ribosylated at Arg177 turns G-actin into a capping protein, which binds to 
the barbed ends of the actin filaments and blocks the addition of non-modified G-actin to this 
end. On the other hand, ADP-ribosylated G-actin does not affect the pointed end of the actin 
filament (Barth and Aktories, 2011). Mono-ADP-ribosylation of G-actin inhibits assembly of 
F-actin strands through steric hindrance of hydrophobic loop interactions between G-actin 
molecules.  
Pathogen disruption of the eukaryotic cytoskeleton through the ADP-ribosylation of 
actin can alter many vital processes, including vesicle trafficking, phagocytosis, migration, 
epithelial barrier formation, and binding to the extracellular matrix, as well as signaling 
(Aktories et al., 2011; Stiles et al., 2011). Furthermore, depolymerization of F-actin affects 
regulation of the dynamic behavior of microtubules and causes tubulin protrusion (Figure 3). 
Toxin-induced formation of the microtubule-based network of protrusions on the surface of 
epithelial cells has major consequences for adherence of bacteria and, thus, influences host–
pathogen interactions (Aktories et al., 2011).  
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Figure 3: Model of the action of toxin-induced formation of the microtubule-based network of 
protrusions. Iota toxin consists of an enzymatic ADP-ribosyltransferase component (Ia) and a binding 
component (Ib). After binding to cell surface receptors, Ib is proteolytically activated and forms heptamers. 
Then, Ia interacts with Ib and the toxin complex is endocytosed into endosome. Under the acidic 
conditions of endosomes, the complex inserts into membranes and finally allows translocation of Ia into 
the cytosol. Ia ADP-ribosylates actin at Arg177 and causes inhibition of actin polymerization. Destruction 
of the actin cytoskeleton has consequences for the microtubule system. Growing microtubules are no 
longer captured at the cell membrane and form long protrusions extending from the cell surface. These 
protrusions facilitate adherence and colonization of bacteria. Modified from Aktories et al., (2011) and 
Stiles et al., 2011.  
 
C. perfringens iota-like enterotoxin (CPILE) 
C. perfringens gastroenteritis is characterized mainly by diarrhea and abdominal pain. 
To date, C. perfringens enterotoxin (CPE) has been considered to be the only virulence factor 
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responsible for the gastrointestinal symptoms reported in C. perfringens type A food-borne 
outbreaks. On the other hand, non-CPE-producing C. perfringens is considered to be non-
diarrheagenic and is a normal flora in humans and animals (Monma et al., 2015). To diagnose 
C. perfringens type A food poisoning, the presence of the cpe and CPE production are 
necessary.  
There were four strange food-borne diseases in Japan during 1997–2010 in which a 
new type of enterotoxin produced by C. perfringens was strongly suspected to be the cause 
on the basis of epidemiological information and bacteriological investigations of the isolates 
(Yonogi et al., 2014; Monma et al., 2015; Irikura et al., 2015). The first two outbreaks 
occurred in 1997 and 2003 in Tokyo followed by another two similar outbreaks in Osaka 
(2009) and Tochigi (2010). The isolated OS1 (Osaka) and TS1 (Tochigi) strains were C. 
perfringens type A. They were closely related large plasmids despite their distinct genetic 
backgrounds (Yonogi et al., 2014). In addition, the Tokyo outbreaks were serotype TW27, 
similar to the OS1 strain, and differed from serotype TW21 of the TS1 strain (Monma et al., 
2015).  
The isolates did not harbor the cpe nor produce CPE even though the clinical 
symptoms of the patients and epidemiological characteristics indicated that the outbreaks 
were caused by C. perfringens. The isolated OS1 and TS1 strains were named binary 
enterotoxin of C. perfringens (BEC), whereas the W5052 strain was called C. perfringens 
iota-like enterotoxin (CPILE). However, it has been shown that BEC and CPILE were 
identical on the basis of the results of a BLAST search (Irikura et al., 2015).  
The culture supernatant of C. perfringens strain W5052 caused the death of Vero cells 
and L929 cells that lack the CPE receptor. Interestingly, the trypsin-treated rCPILE-b alone 
also killed both kinds of cells at high concentration, whereas glutathione S-transferase (GST)-
fused rCPILE-b did not (Figure 4). This finding indicated that the pro-sequence must be 
cleaved before biological activity can occur. Moreover, the cytotoxicity to the Vero cells and 
L929 cells depended on the amount of rCPILE-a added. It should be noted that a mixture of 
rCPILE-a and the trypsin-treated rCPILE-b affected the morphology of L929 cells, which 
showed a balloon-like shape with expanding cytosol, whereas the trypsin-treated rCPILE-b 
did not. This finding probably indicates a different mechanism of action. The polymerization 
of actin may be disrupted by ADP-ribosylation performed by rCPILE-a, whereas the trypsin-
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treated rCPILE-b may induce cytotoxicity through pore-forming activity. The supernatant 
also evoked swelling and fluid accumulation in the ileal loops of rabbits (Irikura et al., 2015).  
 
 
Figure 4: Morphological changes of the L929 cells after treatment with various concentrations of the 
rCPILE of C. perfringens strain W5052. The L929 cells were treated for 16 hours with various 
concentrations of rCPILE-a, trypsin-treated rCPILE-b, and a mixture of rCPILE-a and trypsin-treated 
rCPILE-b. The morphology of the L929 cells was observed by optical microscopy. Source: Irikura et al., 
(2015). PLoS One 10, e0138183. 
 
The enterotoxicity of CPILE was confirmed by rabbit ileal loop assay. Compared with 
cholera toxin, no enterotoxic effects of the W5052 strain were observed at low concentrations 
of a mixture of rCPILE-a and trypsin-treated rCPILE-b (Figure 5; loop 2). On the other hand, 
the ileal loop became dark red, swollen, and showed fluid accumulation at high 
concentrations of the mixture (Figure 5; loop 3 and loop 4). CPILE exerted dose-dependent 
enterotoxic effects (Irikura et al., 2015).  
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Figure 5: The rabbit ileum loop test for the rCPILE of the Clostridium perfringens strain W5052. 
Fluid accumulation was observed in several ileal loops (arrows) in response to the injected rCPILE. Loop 1, 
saline; loop 2, rCPIILE-a (0.1 μg) and trypsin-digested rCPILE-b (0.9 μg); loop 3, rCPILE-a (1 μg) and 
trypsin-treated rCPILE-b (9 μg); loop 4, rCPILE-a (10 μg) and trypsin-treated rCPILE-b (90 μg); and loop 
5, cholera toxin (1 μg). Source: Irikura et al., (2015). PLoS One 10, e0138183. 
 
Objective 
 As described above, CPILE-a was characterized and studied; however, structural and 
functional information for this enzyme was lacking. To gain insight into the CPILE-a 
mechanism of action, enzyme-substrate selection, and recognition of clostridia-toxin-like 
ADP-ribosylating toxins (ARTC), this study had two main objectives: 1) to characterize 
CPILE-a in terms of structure and function and 2) to compare CPILE-a with Ia. The crystal 
structures of apo-, NAD
+
, and NADH-CPILE-a will be useful for understanding the 
structure–function relationship of this novel enterotoxin. The mimicry of the CPILE-a-R177A 
interaction through the E49R mutant may show the enzyme-substrate specificity as 
representative of the other ARTC members. 
 
 
…………………………………… 
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Chapter I 
Crystallization and Structure determination of CPILE-a 
Expression and purification of CPILE-a 
To determine the structure of CPILE-a, three kinds of GST-tagged pGEX4T-
2/CPILE-a were expressed in Escherichia coli. The CPILE-a of interest included 1) wild-type 
CPILE-a, 2) selenomethionine-labeled CPILE-a, and 3) triple cysteine-mutated CPILE-a. The 
triple cysteine mutants were A97C, S185C, and S366C. Then, the CPILE-a in E. coli culture 
was purified by using affinity chromatography followed by gel filtration chromatography. 
The GST-tag was cleaved by thrombin. The GST-tagged CPILE-a was 73.5 kDa as shown in 
the Sepharose without thrombin lane, whereas the purified CPILE-a was 47.5 kDa after 
thrombin cleavage, as shown in the flow-through with thrombin and fraction numbers 28–35 
lanes. The GST was 26 kDa as shown in the Sepharose with thrombin lane. (Figure 6).  
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Coomassie Brilliant Blue stain of the purified CPILE-a. Protein marker ran on the left. It 
should be noted that the first seven lanes were collected from an Affinity column, and the next eight lanes 
on the right were collected from a Superdex 200 column. 
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There was not much difference in the expression and purification among all of the 
mutants and wild-type CPILE-a  except that the yields of purified selenomethionine-labeled 
CPILE-a and triple cysteine-mutated CPILE-a were much lower than that of the wild-type 
CPILE-a.  
 
Crystallization of CPILE-a 
Theoretically, protein crystallization should occur when the concentration of protein 
and precipitant are higher than the threshold value. The closed system of the hanging drop 
method allows vapor diffusion to occur; hence, the protein/precipitant solution reaches 
equilibrium. The solution concentration ranges from unsaturated to supersaturated with 
protein. The unsaturated area has low concentrations of protein and precipitant, and the 
supersaturated area has high concentrations of protein in solution (Figure 7 and 8).  
 
 
 
Figure 7: Hanging drop system and growing crystals. The hanging drop is a closed system composed of 
two main components: a basin and a cover slip. This system is sealed by grease to protect the protein drop 
from air and allow simultaneously exchange of the mother liquor in the drop and in the basin until 
equilibrium occurs. Modified from Rhodes G., 2006. 
 
21 
 
Only the supersaturated area allows nucleation and/or crystal growth. However, the 
supersaturated solution is unstable. An ideal strategy for growing large crystals is to allow 
nucleation to occur under conditions in the blue region, then to move to conditions in the 
green region until crystal growth ceases (Rhodes G., 2006; Figure 7 and 8).  
The phase diagram below shows the conditions under which crystallization of the 
protein occurs (Figure 8). The protein solubility can be divided into three regions: 
undersaturated (stable), supersaturated (metastable and labile), and very highly supersaturated 
(precipitation). In the undersaturated region, the concentrations of protein and precipitant are 
relatively low. Proteins are in random orientation surrounded by mother liquor, including 
water and precipitant. Once protein molecules cross the solubility line (magenta line), the 
mother liquor becomes metastable and the proteins enter a supersaturated state. However, 
there is no spontaneous nucleation. In this state, protein molecules may form transient nuclei 
but they do not reach critical size. An external stimulus, such as seeding, may be necessary to 
induce crystallization (Rupp B., 2003).  
 Homogenous nucleation occurs and reaches critical size, while further supersaturation 
of the solution occurs in the labile region. However, better crystals grow continuously in the 
metastable region in contrast to the labile region.  
 
 
Figure 8: Phase diagram for crystallization of CPILE-a. The cerise color represents a region of low 
concentration of protein and precipitant. The green and blue colors represent regions of supersaturation 
with protein. The brown color represents a region of very high supersaturation with protein. Modified from 
Rupp B. (2003); Rhodes G. (2006); McPherson A. and Gavira JA. (2014). 
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After a number of trials of crystal screening performed by using several Hampton 
screening kits, we concluded that polyethylene glycol (PEGs) were good precipitants and 
suitable for CPILE-a crystallization. Moreover, Tris HCl buffer at high pH and MgCl2 salt 
were a good combination for CPILE-a crystallization. On the other hand, alcohol-based 
solutions were not suitable for CPILE-a and probably denatured it. Purified CPILE-a was 
crystallized by using the standard Hampton screening system and the hanging drop method. 
In this study, the purified CPILE-a was subjected to supersaturated conditions by varying the 
concentration of the PEG 4000 in the droplet (Figure 9). The CPILE-a screening plates were 
screened and kept at 4 °C until data collection. 
 
 
Figure 9: CPILE-a crystals via hanging drop method. A–C Wild-type CPILE-a crystals showing 
cylindrical and hexagonal shapes. It should be noted that a variety of crystal shapes from A to C were 
generated by using seeding technique. D–F Selenomethionine-labeled CPILE-a crystals showing the 
typical CPILE-a crystal shape. G–I Triple cysteine-mutated CPILE-a crystals showing blades or trees 
shapes. 
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When using the Hampton screening kit #6, which consists of PEG 4000, 100 mM Tris 
HCl Buffer at pH 8.5, and 200 mM MgCl2 salt, the purified CPILE-a took < 3 days to form 
crystals. The typical shapes of the CPILE-a crystal were trapezoidal and hexagonal (Figure 
9C-F). Cylindrical shapes were formed in seeded MOPS (3-(N-morpholino) propane sulfonic 
acid) buffer crystal. The most abundant shapes of triple cysteine-mutated CPILE-a crystals 
were thin, fragile, and formed blades or trees (Figure 9G-H). However, the more typical 
shapes of CPILE-a crystals were selected carefully and used for data collection (Figure 9I).  
 
Structure determination of CPILE-a 
The first attempt at structure determination of CPILE-a started with the wild-type 
crystals (Figure 10). At this trial, there was a problem determining the correct space group of 
CPILE-a. The I222 and C222 were found in data collection of the wild-type CPILE-a crystals. 
Several attempts to solve the structure of wild-type CPILE-a by using Ia (1GIQ) as a 
structural template for the molecular replacement (MR) method failed because of the phase 
problem (Taylor, 2003). The R-work and R-free did not decrease. The R-work value 
represents how well the simulated diffraction pattern matches the experimentally observed 
diffraction pattern. However, it may introduce bias into the refinement process. Thus, 10% of 
the experimental observations are removed from the data set before refinement. The R-free 
value is then calculated, and a refinement process using remain data set is performed. The R-
free value represents how well the model predicts relative to the prediction using the 
excluded 10% data set.  
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Figure 10: Schematic of phase determination of CPILE-a I222 crystal.  
The MR failed for two reasons: the wrong space group and/or wrong model search 
was used or both. To solve the phase problem, selenomethionine-labeled CPILE-a and the 
anomalous scattering method were used. Multi-wavelength Anomalous Diffraction (MAD) 
and Single-wavelength Anomalous Diffraction (SAD) had been used to locate the 
selenomethionine. Unfortunately, those two methods failed again. The third attempt used 
heavy atom soaking of the triple cysteine-mutated CPILE-a. Several pieces of evidence 
showed that successful phase determination by mercuration of cysteine was achieved 
(Blundell and Johnson, 1994). However, CPILE-a had no cysteine residue; thus, it was 
necessary to make a cysteine mutant for heavy atom soaking. The triple cysteine mutants 
modified CPILE-a at Ala97, Ser185, and Ser366 in the third try.  
The triple cysteine mutant CPILE-a was expressed, purified, and crystallized in the 
same manner as the wild-type CPILE-a. Then, the crystals were soaked in 1 mM mercury 
chloride mother liquor for 22 hours. Next, the data sets at three different wavelengths for 
peak, edge, and remote were collected by using an NW-12A beamline in KEK PF-AR (Table 
3). 
Additionally, an isomorphous crystal was detected and soaked with platinum chloride 
solution for 22 hours. Then, the data sets at the three different wavelengths were collected by 
using the same NW-12A beamline. Both heavy atom-soaked data sets were used for phase 
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determination by using program suite SHELX C/D/E (Schneider and Sheldrick, 2002; 
Sheldrick, 2008; Sheldrick, 2010). 
 
 
 
 
 
 
 
 
 
 
Table 3: Data collection of native and heavy atom-soaked CPILE-a. 
Data collection Wild type CPILE-a Hg-soaking triple 
cysteine  
mutated CPILE-a 
Pt-soaking triple 
cysteine  
mutated CPILE-a 
Space group I222 I222 I222 
Cell dimensions    
a, b, c (Å) 70.3, 100.7, 126.0 70.2, 101.5, 126.5 70.4, 99.9, 125.6 
a, b, g (°) 90.0, 90.0, 90.0 90.0, 90.0, 90.0 90.0, 90.0, 90.0 
X-ray source MicroMax-007, RAXIS 
VII (RIGAKU) 
PF-AR NW 12A PF-AR NW 12A 
Wavelength (Å) 
 
1.5418 Peak:              1.0070 
Edge:             1.0099 
Remote H:     0.9937 
Peak:              1.0725 
Edge:             1.0729 
Remote L:     1.0775 
Resolution 
range (Å) 
50.00-2.01 (2.04-2.01) 50.00-2.20 (2.24-2.20) 50.00-1.99 (2.02-1.99) 
Observed 
reflections 
198493 255478 335650 
Rmeas
a
 0.099 (0.660) 0.098 (0.491) 0.069 (0.382) 
Rpim
b
 0.037 (0.262) 0.041 (0.206) 0.028 (0.166) 
CC1/2
c
 (0.885) (0.927) (0.957) 
I / σI (%) 31.2 (2.9) 29.8 (5.8) 37.4 (5.1) 
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Completeness 
(%) 
98.3 (85.8) 100.0 (100.0) 99.9 (100.0) 
Redundancy 6.7 (5.2) 5.8 (5.7) 5.7 (5.2) 
aRmeas = ∑ {𝑁(ℎ𝑘𝑙) [𝑁(ℎ𝑘𝑙) − 1]⁄ }
1
2ℎ𝑘𝑙 ∑ |𝐼𝑖(ℎ𝑘𝑙) − 〈𝐼(ℎ𝑘𝑙)〉|𝑖 ∑ ∑ 𝐼𝑖(ℎ𝑘𝑙)𝑖ℎ𝑘𝑙⁄ , 
bRpim = ∑ {1 [𝑁(ℎ𝑘𝑙) − 1]⁄ }
1
2ℎ𝑘𝑙 ∑ |𝐼𝑖(ℎ𝑘𝑙) − 〈𝐼(ℎ𝑘𝑙)〉|𝑖 ∑ ∑ 𝐼𝑖(ℎ𝑘𝑙)𝑖ℎ𝑘𝑙⁄ , where    𝐼𝑖(ℎ𝑘𝑙) are the observed intensities, 〈𝐼(ℎ𝑘𝑙)〉 is the average 
intensity and 𝑁(ℎ𝑘𝑙) is the multiplicity of reflection ℎ𝑘𝑙. 
cCC1/2 = percentage of correlation between intensities from random hkl-data sets 
 
 
 
 
 
 
 
 
 
Table 3 presents the data collection summary of three data sets: wild-type CPILE-a, 
Hg-soaked triple cysteine-mutated CPILE-a, and Pt-soaked triple cysteine-mutated CPILE-a. 
The wild-type CPILE-a data set was collected by using in-house x-ray diffractometer at 
Kyoto Sangyo University, whereas the heavy atom-soaked data sets were collected at the 
Photon Factory. The data are summarized in Appendix A. 
As a starting point, SHELXC was used to prepare input for SHELXD. Then, 
SHELXD was used to find the substructure. At this point, SHELXD plotted the substructure 
coordinates of a subset of atoms within the same unit cell. Once SHELXD was able to plot 
the substructure coordinates, they were used to overcome the phase problem. The success 
criterion was the correlation coefficient between Eobs and Ecalc. In the case of SAD, a CCall 
value of > 30% was a good indication of a correct solution (Schneider and Sheldrick, 2002; 
Sheldrick, 2008; Sheldrick, 2010). SHELXE was used to autotrace of the peptide backbone 
and report the poly-Ala polypeptide chains model as a pdb file. If the value of CC for the 
partial structure against the native data was > 30%, it was a strong indicator of a successful 
structure solution. Another value was the Pseudo-free CC, which indicated a successful 
structure solution if this value was > 65% (Grüne, 2010).  
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The heavy atom data sets were used for the phasing of the MAD and SAD calculation 
by SHELX (Table 4 and Table 5). The Figure of Merit (FOM) of the Hg-soaked data sets 
showed that MADori and MADinv were 0.525 and 0.500, respectively (Table 4). The FOM of 
SADori and SADinv were 0.589 and 0.536, respectively. The origin (ori) and invert (inv) show 
the right-hand and left-hand coordinate, respectively. The correct hand shows a high FOM. 
MADori was better than MADinv, so MADori was the correct answer. SADori was also better 
than SADinv, so SADori was the correct answer. The highest pseudo-free CC of 64.29% 
belonged to the SADori data. The CC for the partial structure against the native data also 
showed the highest value at 31.34% for SADori. Taken together, among the Hg-soaked data 
sets, SADori gave the best results. 
 
 
 
 
 
Table 4: Statistics of SHELX phasing; Hg MAD and SAD experiment. 
Hg position (MADori) FOM Pseudo-free CC 
(%) 
CC
a
 
(%) 
C-tracingb 
Site x y z 
1 
2 
3 
0.0684 
0.3260 
-0.0993 
0.7233 
0.6940 
0.8025 
0.0871 
0.0086 
0.0497 
0.525 57.27 7.79 15 (143) 
Hg position (MADinv) FOM Pseudo-free CC 
(%) 
CC
a
 
(%) 
C-tracingb 
Site x y z 
1 
2 
3 
0.9316 
0.6740 
1.0993 
0.2767 
0.3060 
0.1975 
0.9129 
0.9915 
0.9503 
0.500 54.02 5.60 14 (125) 
Hg position (SADori) FOM Pseudo-free CC 
(%) 
CC
a
 
(%) 
C-tracingb 
Site x y z 
1 
2 
3 
0.5685 
0.8262 
0.4054 
0.7770 
0.8053 
0.6976 
0.0870 
0.0085 
0.0485 
0.589 64.29 31.34 18 (344) 
Hg position (SADinv) FOM Pseudo-free CC CC
a
 C-tracingb 
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Site x y z (%) (%) 
1 
2 
3 
0.4315 
0.1738 
0.5946 
0.2230 
0.1947 
0.3024 
0.9130 
0.9915 
0.9514 
0.536 58.46 5.47 15 (139) 
a
CC for partial structure against native data 
b
Number of C-tracing chains; Number of C-tracing residues showed in parenthesis. 
 
 
 
 
 
 
 
 
 
For the Pt-soaked data sets, the highest pseudo-free CC of 62.95% belonged to SADori 
data (Table 5). The CC for the partial structure against the native data showed the highest 
value at 11.84% for SADori. Among the Pt-soaked data sets, SADori gave the best results. 
 
Table 5: Statistics of SHELX phasing; Pt MAD and SAD experiment. 
Pt position (MADori) FOM Pseudo-free CC 
(%) 
CC
a
 
(%) 
C-tracingb 
Site x y z 
1 
2 
3 
4 
0.7271 
0.7638 
0.7446 
0.7368 
0.4301 
0.4064 
0.4142 
0.2650 
0.0108 
0.0185 
-0.0407 
-0.0156 
0.466 51.53 4.04 13 (113) 
Pt position (MADinv) FOM Pseudo-free CC 
(%) 
CC
a
 
(%) 
C-tracingb 
Site x y z 
1 
2 
3 
0.2729 
0.2362 
0.2554 
0.5699 
0.5936 
0.5858 
0.9892 
0.9815 
1.0407 
0.496 55.02 4.86 11 (94) 
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4 0.2632 0.7350 1.0156 
Pt position (SADori) FOM Pseudo-free CC 
(%) 
CC
a
 
(%) 
C-tracingb 
Site x y z 
1 
2 
3 
4 
0.7724 
0.7385 
0.6876 
0.6874 
0.9309 
0.9047 
0.8064 
0.9175 
0.0105 
0.0178 
-0.0070 
0.0192 
0.566 62.95 11.84 14 (272) 
Pt position (SADinv) FOM Pseudo-free CC 
(%) 
CC
a
 
(%) 
C-tracingb 
Site x y z 
1 
2 
3 
4 
0.2276 
0.2615 
0.3124 
0.3126 
0.0691 
0.0953 
0.1936 
0.0825 
0.9895 
0.9822 
1.0070 
0.9808 
0.524 58.28 6.85 15 (132) 
a
CC for partial structure against native data 
b
Number of C-tracing chains; Number of C-tracing residues showed in parenthesis. 
 
 
 
The Hg-soaked and Pt-soaked data sets were used to locate the heavy atoms in the 
asymmetric unit. The SHELXE data showed that the Hg-soaked SADori data was the best 
followed by the Pt-soaked SADori data. Therefore, these two data sets were used to represent 
the results of C-tracing by SHELX (Figure 11).  
Figure 11 shows the C-tracing of the Hg-soaked CPILE-a on the left and Pt-soaked 
CPILE-a on the right. The SHELX results were for several fragments of the poly-Ala 
polypeptide chain. For the Hg-soaked SAD data set, the results of C-tracing showed 344 
alanine residues in 18 polypeptide chains, whereas the results of C-tracing of the Pt-soaked 
SAD data set represented 139 alanine residues in 15 polypeptide chains. After review of the 
SHELXE results, the Hg-soaked SADori data set was selected and subjected to model 
building because it showed the best results from the C-tracing. Those fragments were then 
filled up to 419 amino acid residues by using ARP/wARP as an automated model building 
program (Langer et al., 2008). Then, the full-length Hg-soaked model was used as a search 
model for refining the wild-type CPILE-a data set.  
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Figure 11: C tracing using SHELX. The poly-alanine polypeptides of Hg-soaked triple cysteine-
mutated CPILE-a is shown on the left and the poly-alanine polypeptides of the Pt-soaked triple cysteine-
mutated CPILE-a is shown on the right. Both of them support the original structure of SHELX. 
 
The wild-type CPILE-a structure was solved at 2.01 Å by using MR method and the 
Hg-soaked SADori structure as a search model. Wild-type CPILE-a belongs to a member of 
the I222 space group and is composed of one molecule in an asymmetric unit (Table 6).  
 
Table 6: Refinement statistics of wild type CPILE-a. 
Refinement Wild type CPILE-a 
Resolution (Å) 21.8-2.01 
Rwork/Rfree 
a
 (%) 17.6 / 22.9 
Overall B factors (Å
2
) 44.0 
r.m.s.deviations  
Bond lengths (Å) 0.007 
Bond angles (°) 1.084 
Ramachandran plot   
Favored regions (%) 97.35 
Allowed regions (%) 2.41 
Outliers (%) 0.24 
PDB ID 5GTT 
aRwork = ∑ ||𝐹𝑜𝑏𝑠| − |𝐹𝑐𝑎𝑙𝑐||ℎ𝑘𝑙 ∑ |𝐹𝑜𝑏𝑠|ℎ𝑘𝑙⁄ . Rfree is the cross-validation R factor for the test set (5%) of reflections  
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omitted from model refinement. 
 
Later, we evaluated the binding site of Hg-soaked and Pt-soaked data sets using the 
final structure. In the case of Hg-soaking, only three large electron density regions were 
detected: the triple cysteine-mutated CPILE-a composed of A97C, S185C, and S366C. 
However, only Cys185 and Cys366 showed a large peak in the |Fo-Fc| map. Interestingly, the 
third large peak was found near His157 (Figure 12).  
 
Figure 12: Hg-soaked CPILE-a. A–D, the electron density maps of Cys97, Cys185, Cys366, and His157. 
The A97C-mutated CPILE-a showing a small peak in the |Fo-Fc| map that probably represents another 
rotamer of the cysteine residue. Large peaks were found at S185C, S366C, and H157 in the |Fo-Fc| map. 
 
Compared with the Hg-soaked data set, the Pt-soaked CPILE-a showed four large 
electron density regions at Cys97, Cys185, Cys366, and Met8 (Figure 13). Interestingly, the 
biggest electron density region was found at the Met8 site (Figure 13D). In corporation of 
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heavy atoms in the triple cysteine mutant have been responsible for solving the phase 
problem. 
 
 
Figure 13: Pt-soaked CPILE-a. A–D, the electron density maps of Cys97, Cys185, Cys366, and Met8. 
Electron density maps for Pt atoms at the triple cysteine residues and the biggest |Fo-Fc| map was located 
at the methionine residue. 
 
Structure of CPILE-a 
CPILE-a is comprised of 419 amino acid residues and can be divided into two 
domains: the N-terminal domain (1-211) and C-terminal domain (212-419). The structures of 
the N-terminal domain and C-terminal domain of CPILE-a were quite similar even though 
the sequence identity was low (28.87%). The overall structure of CPILE-a was composed of 
two sets of -strands and -helices (Figure 14). The core structure of CPILE-a is constructed 
from five -strands (four strands in N-terminal domain) and a set of three anti-parallel -
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sheets. Interestingly, there was a long loop at the junction between the N- and C-terminal 
domains. The arrangement of the N-domain was found to be 1, 2, 3, 4, 1, 5, 6, , 2, 
3, 4, 5, 6, and 7 followed by 7, 8, 9, 10, 8, 11, 12, 13, 9, 10, 11, 12, 
14, 15, 13, and 14 of the C-terminal domain. Moreover, there were three flexible loops 
that should be carefully investigated to determine their roles on actin binding, including loop 
I, protruding loop I (PT I), and protruding loop II (PT II) (magenta color in Figure 14). 
 
 
 
 
 
 
 
Figure 14: Crystal structure of CPILE-a. The overall structure of CPILE-a is composed of two sets of -
strands and -helices. N-terminal domain (blue), C-terminal domain (yellow), loop I, PT I, and PT II 
(magenta). 
 
A Ramachandran plot showed a 2-dimensional scatter plot of the φ-ϕ backbone 
torsion angle pairs for each residue of CPILE-a (Figure 15). The 402 amino acid residues 
were in the preferred region, and 11 residues and two residues were in the allowed and outlier 
regions, respectively.  
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Figure 15: Ramachandran plot of CPILE-a. Most amino acid residues are in the -region and right 
helical region. There are two outlier residues: Ala11 and Asn115. 
To confirm that the structure of CPILE-a was solved correctly, the electron density 
map was captured at 1.09 rmsd. The amino acid residues fit well to the electron density map 
shown (Figure 16).  
 
 
Figure 16: |Fo-Fc| map of CPILE-a at the 1.09 σ map contour level. Isoleucine residues fit to the 
electron density map are shown. 
 
Comparison with Iota toxin (Ia) 
1.1 Sequence comparison 
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On the basis of the family of amino acid residues at three positions essential for NAD-
binding, ARTs can be divided into two major subclasses: ARTC (Clostridia toxin-like/ 
Cholera toxin-like) carrying the RSE triad motif and ARTD (Diphtheria toxin-like) carrying 
the HYE triad motif (Hottiger et al., 2010). Several studies have shown that the asparagine or 
arginine specificity is governed by the first Gln or Glu of the Q/ExE motif (Hara et al., 1996; 
Maehama, Hoshino, and Katada, 1996; Han et al., 2001; Vogelsgesang and Aktories, 2006). 
This residue is positioned two residues upstream of the catalytic Glu. It is also present in the 
variant R-S-E triad motif. CPILE-a and Ia belong to the ARTC subfamily.  
The sequence alignment of CPILE-a and Ia show high identity and have similar 
residues, especially in the RSE triad motif, which are conserved between them (Figure 17). 
The RSE motif consists of three -strands located in the C-terminal domain (yellow circle). 
The first aromatic-R on RSE motif is located between loop II and loop III. The STS motif is 
located between loop III and loop IV. CPILE-a has STT instead of the STS as in Ia. The EXE 
motif is located on the ARRT loop.  
 
 
 
 
 
 
 
 
 
 
Figure 17: Sequence alignment of CPILE-a and Ia. The black boxes show actin-binding loops (I-V) 
based on the Ia–actin crystal structure. The Ia five loops are named loop I (Tyr61-Tyr62), loop II (active 
site loop), loop III, loop IV (PN loop), and loop V (ARTT loop) (Tsuge et al., 2008). Yellow circles 
represent the RSE triad motif.  
 
PT I 
PT II 
II 
III IV 
V 
I 
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1.2 Structural comparison 
The overall crystal structure of CPILE-a is similar to that of Ia at the RMSD 1.56 Å of 
360 amino acid residues compared. However, CPILE-a has two extra-long loops, including 
PT I and PT II, which represent a distinct difference from Ia (Figure 18). Those distinct loops 
are not located around the NAD binding cleft and probably do not affect NAD binding. 
Interestingly, the conformation of loop I of CPILE-a is different from that of Ia, which are 
important for actin binding. CPILE-a harbors Leu61, Asp62, and Asn63, whereas Ia has 
Tyr61, Asp62, and Tyr63. However, based on the structural difference between CPILE-a and 
Ia, several key residues of loop I, PT I, and PT II were selected and mutated for the ADP-
ribosyltransferase study. The amino acid residues of interest were Leu61 and Asn63 from 
loop-I, Glu266Asn267 from PT-I, and Ser404 and Leu405 from PT-II.  
 
Figure 18: Structural comparison between CPILE-a and Ia. Superimposed structures of CPILE-a 
(5GTT) and Ia (4H03). The marine color represents the C-terminal domain, and the yellow color represents 
the N-terminal domain of CPILE-a, whereas the N-terminal domain and C-terminal domain of Ia are 
shown in cyan and white, respectively. NAD
+
 is shown as a stick. Close-up views of loop-I and PT-II are 
on the left, and PT-I is on the right. Some of amino acid residues selected for the mutational study are 
shown as a stick.  
37 
 
 
Discussion and Conclusion 
Structural determination of CPILE-a 
 At first glance, we faced the phase problem because of at least two space groups (I222 
and C222) of the CPILE-a crystal. We could not solve the structure by MR. However, we 
overcame the phase problem on the third try by using MAD and SAD data sets of Hg-soaked 
CPILE-a. Compared with Ia, CPILE-a showed three distinct loops, including a short loop I 
and two protruding loops, I and II. In Ia, Tyr60 and Tyr62 of loop I interact with actin 
through an ionic bond and hydrogen bond, respectively (Tsurumura et al, 2013). In contrast, 
Tyr60 and Tyr62 of loop I in CPILE-a were substituted by Leu61 and Asn63, respectively. 
Therefore, loop I mutants were used to test the ADP-ribosyltransferase activity as described 
in chapter IV. Moreover, PT I and PT II mutants were also tested.  
 
 
…………………………………… 
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Chapter II 
Structural analysis of NAD
+
 and NADH-binding CPILE-a 
NAD
+
-binding and NADH-binding of CPILE-a 
NAD
+
 is a cofactor of ARTs whereas NADH is not. Therefore, CPILE-a and both 
substances were co-crystalized and analyzed. The NAD
+
-CPILE-a and NADH-CPILE-a 
structures were solved at 1.80 Å and 2.26 Å, respectively. The NAD
+
-CPILE-a data set was 
collected by using an NW-12A beamline in a KEK Photon Factory-Advanced Ring, whereas 
NADH-CPILE-a was collected in-house by using a MicroMax-007 generator and RAXIS VII 
X-ray diffractometer (Rigaku) at Kyoto Sangyo University. Both structures were solved by 
MR and wild-type CPILE-a as a structural model. Both of them belonged to the I222 space 
group and were one molecule in an asymmetric unit (Table 7).  
Table 7: Data collection of NAD
+
-CPILE-a and NADH-CPILE-a 
Data collection NAD
+
-CPILE-a NADH-CPILE-a 
Space group I222 I222 
Cell dimensions   
a, b, c (Å) 70.0, 95.2, 125.1 70.6, 101.6, 125.3 
a, b, g (°) 90.0, 90.0, 90.0 90.0, 90.0, 90.0 
X-ray source PF-AR NW 12A  MicroMax-007, RAXIS VII (RIGAKU) 
Wavelength (Å) 1.00000 1.5418 
Resolution range (Å) 50.00-1.80 (1.83-1.80) 50.00-2.26 (2.30-2.26) 
Observed reflections 242720 127629 
Rmeas
a
 0.152 (0.844) 0.084 (0.408) 
Rpim
b
 0.060 (0.370) 0.034 (0.169) 
CC1/2
c
 (0.655) (0.948) 
I / σI 12.3 (0.92) 41.3 (6.5) 
Completeness (%) 99.4 (92.1) 98.4 (95) 
Redundancy 6.3 (4.8) 6.0 (5.4) 
aRmeas = ∑ {𝑁(ℎ𝑘𝑙) [𝑁(ℎ𝑘𝑙) − 1]⁄ }
1
2ℎ𝑘𝑙 ∑ |𝐼𝑖(ℎ𝑘𝑙) − 〈𝐼(ℎ𝑘𝑙)〉|𝑖 ∑ ∑ 𝐼𝑖(ℎ𝑘𝑙)𝑖ℎ𝑘𝑙⁄ , 
bRpim = ∑ {1 [𝑁(ℎ𝑘𝑙) − 1]⁄ }
1
2ℎ𝑘𝑙 ∑ |𝐼𝑖(ℎ𝑘𝑙) − 〈𝐼(ℎ𝑘𝑙)〉|𝑖 ∑ ∑ 𝐼𝑖(ℎ𝑘𝑙)𝑖ℎ𝑘𝑙⁄ , where     𝐼𝑖(ℎ𝑘𝑙) are the observed intensities, 〈𝐼(ℎ𝑘𝑙)〉 is the 
average intensity and 𝑁(ℎ𝑘𝑙) is the multiplicity of reflection ℎ𝑘𝑙. 
cCC1/2 = percentage of correlation between intensities from random hkl-data sets 
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 The NAD
+
-CPILE-a and NADH-CPILE-a structures were deposited as 5WTZ and 
5WU0, respectively, in the Protein Data Bank (Table 8). 
Table 8: Refinement statistics of NAD
+
-CPILE-a and NADH-CPILE-a 
Refinement NAD
+
-CPILE-a NADH-CPILE-a 
Resolution (Å) 47.61-1.80 23.48-2.25 
Rwork/Rfree 
d
 (%) 19.0 / 23.8 17.7 / 24.8 
Overall B factors (Å
2
) 32.0 47.0 
r.m.s.deviations   
Bond lengths (Å) 0.007 0.007 
Bond angles (°) 1.124 1.166 
Ramachandran plot    
Favored regions (%) 96.39 95.20 
Allowed regions (%) 3.13 4.32 
Outliers (%) 0.48 0.48 
PDB ID 5WTZ 5WU0 
aRwork = ∑ ||𝐹𝑜𝑏𝑠| − |𝐹𝑐𝑎𝑙𝑐||ℎ𝑘𝑙 ∑ |𝐹𝑜𝑏𝑠|ℎ𝑘𝑙⁄ . Rfree is the cross-validation R factor for the test set (5%) of reflections  
omitted from model refinement. 
 
 The superimposed structure of NAD
+
-CPILE-a and NADH-CPILE-a showed that 
there were no distinct structural differences in the 356 amino acid residues compared between 
them at RMSD 0.232 Å (Figure 19).  
 
Figure 19: Superimposed structure of NAD
+
-CPILE-a (5WTZ) and CPILE-a-NADH (5WU0). For 
NAD
+
-CPILE-a labeled here, N-domain (marine blue); C-domain (yellow); NADH-CPILE-a (gray). 
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 Figure 20 shows close-ups of the NAD
+
- and NADH-binding sites of CPILE-a. No 
large structural difference in the NAD-binding site was seen between the two complex 
structures. 
 
 
Figure 20: Closed up superimposed structure of 5WTZ and 5WU0. For NAD
+
-CPILE-a labeled here, 
N-domain (marine blue); C-domain (yellow); NADH-CPILE-a (gray). 
 
CPILE-a has hydrogen bonds with NAD
+
 and NADH through the side chain of 
Asn256, Arg297, Thr337, Arg354, and Glu382 (Figure 20). The crystal structure of NAD
+
-
CPILE-a confirmed the location of the R (Arg297)-S (Ser340)-E (Glu382) motif around 
NAD cleft. Agr297 is located close to the O1N and O2N (N-phosphate) of NAD
+
. As 
mentioned previously in chapter I, the second “S” of the STS motif was replaced by threonine 
in CPILE-a; thus, it did not seem to be very important to compare it with the first “S”. 
Glu382 is the latter glutamate on the conserved EXE motif. The carbonyl and amide of the 
main chain Arg298 also fixed the nicotinamide in both the NAD
+
- and NADH-binding 
structures. 
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Comparison with Iota toxin (Ia) 
 Superimposition of CPILE-a and Ia in the same direction of NAD
+
 demonstrated that 
only 11 residues of CPILE-a form NAD
+
 binding cleft, including Tyr252, Arg297, Arg298, 
Gly300, Asn302, Glu303, Thr337, Ser340, Thr341, Phe351, and Glu382. As we already 
described in chapter I, there were no large differences between CPILE-a and Ia except for 
loop I, PT-I, and PT-II. However, we noticed that there were some differences especially near 
the NAD-binding site, which caused moderate conformational differences even though the 
nine residues were conserved at RMSD 1.246 Å (Figure 21).  
 
 
Figure 21: Comparison with NAD
+
 binding site of CPILE-a and Ia. Stereo-view of NAD
+
-CPILE-a 
(yellow) and NAD
+
-Ia (4H03; gray) focused on the ligand-binding site (NAD
+
). Nine residues represent 
the close-contact residues to NAD
+
. All residues labeled here belong to NAD
+
-CPILE-a. 
 
In other words, although these nine residues around the NAD-binding site were 
conserved in the tertiary structures of Ia and CPILE-a, CPILE-a has a narrower NAD-binding 
pocket than that of Ia (Figure 22). 
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Figure 22: NAD binding pocket. A) NAD
+
-CPILE-a showing a narrow NAD
+
 binding pocket. B) NAD
+
-
Ia. Alpha helix 7 is located on the left side of the NAD molecule. 
 
Discussion and Conclusion 
NAD
+
-binding and NADH-binding of CPILE-a 
 In the next Ligplot-like figure, we summarize the differences between CPILE-a and Ia 
around the NAD-binding site (Figure 23). For Ia (Figure 23B), we also added the results of 
the mutational study (Tsuge et al., 2003). It was known that Glu380 (Glu378 in Ia) and 
Glu382 (Glu380 in Ia) on the EXE motif were important residues for catalysis: the former 
glutamate (Glu380) is important for substrate residue recognition for ADP-ribosyltransferase 
(as will discussed in chapter VI: final discussion), whereas the latter glutamate (Glu382) is 
important for sharing a hydrogen bond with N-ribose (O2D) and for cleavage of 
nicotinamide-ribosyl bond (Oppenheimer, 1994; Han et al., 1999). Thus, Glu380 is a key 
amino acid for NADase, and Glu382 is a key amino acid for both NAD glycohydrolase and 
ADP-ribosyltransferase activities.  
The two arginine, Arg297 (Arg295 in Ia) and Arg354 (Arg352 in Ia), support the 
phosphate groups of NAD. These residues did not appear to cause differences between the 
two structures. Interestingly, Asn256 of CPILE-a (Asn255 in Ia) has some contact with AO2 
of the phosphate group. Asn256 is located on the α7 helix (252YTAINKYL259), and this 
alpha helix appeared to have moved slightly closer to the NAD molecule. This movement 
seems to cause the narrower binding pocket of CPILE-a than that of Ia. In the next chapter, 
we discuss the functional differences in NAD glycohydrolase activity between CPILE-a and 
Ia, which may be caused by this structural difference. 
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Figure 23: Schematic structure of the NAD binding site. A) NAD binding site of CPILE-a showing 
very close α7 helix and the location of Asn256 on the helix. B) NAD binding site of Ia showing distant α7 
helix. The red label indicates the mutational study by Tsuge et al., JMB, 2003.  
 
……………………………………  
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Chapter III 
Study of NADase activity of CPILE-a 
NADase activity 
 Based on the structural similarity of the C-terminal domain with that of Ia, the two 
molecules should exhibit similar enzymatic activities. Despite having ADP-ribosyltransferase 
(ARTase), it is unclear if CPILE-a possesses NAD glycohydrolase (NADase). It is interesting 
to examine why Ia possesses both ADP-ribosyltransferase and NAD glycohydrolase and 
transfers the ADP-ribose moiety to different targets: actin and water. NADase hydrolyzes 
NAD into ADP-ribose and nicotinamide and then transfers the ADP-ribose moiety to a water 
molecule (Figure 24).  
 
Figure 24: NADase reaction and possible substances derived from NAD hydrolysis.  
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Comparison with Iota toxin (Ia) 
There were two purposes of this NADase assay: 1) to explore the NADase activity of 
CPILE-a and 2) to compare the NADase activities of CPILE-a and Ia under three conditions. 
The reactions were incubated at 37°C for 10 minutes and at room temperature for 1 hour or 
overnight. Figure 25A shows the reference peaks of NAD
+
, NADH, ADP-ribose, AMP, 
and nicotinamide. It is interesting that ADP-ribose was the first substance eluted at 
approximately 1.5 minutes after injection followed by a double peak for NAD
+
 then a single 
peak for NADH. Nicotinamide eluted at approximately4.0 minutes and AMP eluted at 
approximately 5.5 minutes.  
 
 
Figure 25: Chromatogram of NAD glycohydrolase activities of CPILE-a and Ia. A) Reference 
substances for NADase assay. All reference substances were loaded at 1 mM. B) NAD glycohydrolase 
activities of CPILE-a and Ia at 37°C, 10 min. C) NAD glycohydrolase activities of CPILE-a and Ia at 37°C, 
10 min. D) NAD glycohydrolase activities of CPILE-a and Ia at room temperature, overnight. 
 
 The ADP-ribose and nicotinamide produced from the NADase assay showed that 
CPILE-a had almost no NADase activity even when incubated at room temperature overnight, 
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whereas Ia showed high NADase activity. It was unclear if CPILE-a cleaved NAD
+
. Thus, a 
similar assay with actin was performed for both CPILE-a and Ia (Figure 26).  
 
 
Figure 26: Chromatogram of NADase activities with actin of CPILE-a and Ia. A) Reference 
substances for NADase assay. All reference substances were loaded at 1 mM. B) NADase activities with 
actin of CPILE-a and Ia at 37°C, 10 min. C) NADase activities with actin of CPILE-a and Ia at 37°C, 10 
min. D) NADase activities with actin of CPILE-a and Ia at room temperature, overnight. Red arrows 
indicate the unidentified peaks at 1.4 and 3.0 minutes. 
 
 Even with actin, the NADase activities of Ia showed a trend similar to that of the  
NADase activities. The amounts of ADP-ribose and nicotinamide increased with time. 
However, there was a difference in the NADase activities with actin between CPILE-a and Ia. 
Interestingly, the NADase activity with actin overnight of CPILE-a showed unidentified 
peaks at 1.4 minutes (Figure 26B, 26C and 26D) and 3 minutes (Figure 26D). It was unclear 
what these peaks represented. It is certain that actin affected the NADase activity of CPILE-a, 
and it is possible that actin triggered another reaction of CPILE-a. These unidentified peaks 
were collected and subjected to analysis by using mass spectrometry, but we were unable to 
identify the peaks.  
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Discussion and Conclusion 
NADase activity 
 Irikura et al. (2015) reported the NADase activity at room temperature (6 hours) of 
rCPILE-a determined by LC/MS/MS. Nicotinamide released in a dose-dependent manner. 
However, our NADase assay showed that CPILE-a had almost no NADase activity even 
incubated at room temperature overnight, whereas Ia showed high NADase activity. The 
NADase activities between CPILE-a and Ia were much different. Furthermore, with actin, 
CPILE-a produced unknown products that were not seen in Ia with actin. The unidentified 
peak at 1.4 minutes (Figure 26B, 26C) decreased to a small peak, as shown in Figure 26D. 
Moreover, the unidentified peak at 3.0 minutes appeared when the reaction time was 
extended to overnight. Actin may induce some change in the NAD binding pocket and induce 
an unknown reaction. However, these products (1.4 minutes) were not stable and were 
transformed to another unidentified product (3.0 minutes). Further investigation regarding 
these observation is needed. 
The site-directed mutagenesis of Ia showed the important roles of Arg295, Glu301, 
Arg352, Glu378, and Glu380 on NADase activity (Tsuge et al., 2003), and these residues 
were conserved in the tertiary structure. Based on the comparative structures of CPILE-a and 
Ia described in the previous chapter, we noticed one helix that included Asn256 was 
positioned closer to NAD and made a narrower pocket of NAD even though the two 
molecules have high sequence similarity. This helix is not only positioned near NAD but also 
related to actin binding, as shown in the Ia–actin structure. The positional difference of this 
helix may cause the difference in NADase activity without and with actin. Whether other 
factors, such as protein dynamics, are related to the catalytic difference unknown. 
 
 
…………………………………… 
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Chapter IV 
Mutational studies of actin binding site in CPILE-a and Ia 
General introduction 
Actin is one of the most conserved proteins in eukaryote evolution and is involved in 
a variety of microfilament systems, such as muscle contraction, cell crawling, cytokinesis, 
cytoplasmic organization, and intracellular transport (Troys et al., 1999). These actins share 
93.3% identity, and their secondary structures are also quite similar (Figure 27). It is 
interesting how bacterial ARTs recognize and distinguish between -actin and/or -actin. 
 
Figure 27: Sequence alignment of -actin and -actin. Red boxes represent sequence identity, 
whereas the blue boxes represent sequence similarity. The figure was generated by using ESPript 3.0 after 
sequence alignment by Clustal Omega.  
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Actin is separated into two lobes by a deep cleft. Each lobe is composed of two 
subdomains (Figure 28). All domains contain a central -sheet surrounded by a varying 
number of -helices (Aktories et al., 2011). Both the N- and C-terminus are located in 
subdomain I. The target ADP-ribosylating Arg177 is located in subdomain III on the barbed 
end.  
 
 
Figure 28: Structure of monomeric G-actin-ANP complex (1NWK). The red circle indicates Arg177, 
which is a target residue of ADP-ribosylating toxin. The orange circles the represent N- and C-termini. 
Modified from Aktories et al., 2011. 
 
The sequence identity of -actin and -actin is very high (93.33%). Only twenty 
seven amino acid residues differ between -actin and -actin. It is interesting how CPILE-a 
can distinguish each type of actin, as will be described later. The ADP-ribosyltransferase 
activity of CPILE-a and CPILE-a-actin interaction were studied by using the Ia–actin 
complex structure as a model. At first, the recognition residues between Ia and actin were 
reviewed as they related to the crystal structure of the Ia–actin complex (4H03). Next, the 
CPILE-a-actin structure was modeled. Then, the selected key residues were mutated and their 
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roles on the ADP-ribosyltransferase activity were tested by using the fluorescein 
isothiocyanate (FITC) technique. Finally, the FITC results of the CPILE-a mutants were 
compared with Ia. 
 
Ia–actin complex 
In 2008, the complex structure of Ia–TAD–actin had been reported (Tsuge et al., 
2008). These complex structures provided insight into the actin binding site (Figure 29). Ia 
interacted with actin in subdomains I–IV through loops I–V. These five Ia loops were named 
loop I (Y61-Y62), loop II (active site loop), loop III, loop IV (PN loop), and loop V (ARTT 
loop), respectively (Tsuge et al., 2008; Sakurai et al., 2009). These loops located near the 
TAD binding cleft were important for actin binding. It should be noted that most actin 
binding sites were in the C-terminal domain of Ia except that Y60-D61-Y62 belonged to loop 
I of the N-terminal domain. Furthermore, the Ia–actin complex also showed that the 
subdomain I, III, and IV of actin were close contact to Ia five loops.  
 
 
 
Figure 29: Butterfly representation of recognition residues between Ia and actin. Roman numerals (I-
V) show the five binding loops in Ia. The actin-recognition residues on the five loops of Ia are shown as 
circles on the left. The catalytic residues of Ia around NAD (Tyr251, Arg295, Arg352, Glu378, and 
Glu380) are shown as sticks. The Ia-recognition residues of actin are shown as circles on the right. N-
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terminal domain (Cyan); C-terminal domain (Yellow); Actin (Green). Source: Tsuge et al., (2008). PNAS 
105, 7399-7404. 
CPILE-a-actin model 
How CPILE-a recognizes its target protein is unclear. Unfortunately, there is no 
known complex structure of CPILE-a-actin. However, Tsuge et al., 2008 showed that the 
structure of actin within the Ia-actin complex was relatively unchanged from its monomeric 
form. Thus, based on the crystal structures of Ia–-actin (4H03), the CPILE-a-actin model 
was constructed. The CPILE-a-actin models were minimized by using Chimera 1.11. 
Therefore, the model of the CPILE-a–actin complex here was used as the template to 
investigate the recognition process of CPILE-a and its target proteins (-actin and -actin). 
This study focused on the interaction surface between CPILE-a and -actin (Figure 30). It 
was interesting that CPILE-a shared most of its surface interaction with -actin through the 
C-domain, similar to Ia. Moreover, it is expected that some part of the N-terminal domain 
was also associated in -actin binding.  
 
 
Figure 30: Model structure of CPILE-a-actin. The red square represents the interaction surface 
between CPILE-a and -actin. (N-terminal domain (marine blue); C-terminal domain (yellow); -
actin, (green). 
 
Focused residues of the actin binding site shown by the CPILE-a-actin model 
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In the CPILE-a-actin model, the interchain contacts were calculated by using the 
Contact program in CCP4 suite software (Bailey, 1994; Winn et al., 2011). The results 
showed that CPILE-a recognized  subdomain III of-actin through loop I (Table 9). Loop 
III of CPILE-a interacted with subdomain IV, whereas members of loop IV were in close 
contact with subdomains III and IV. Interestingly, both protruding loops were involved in the 
interaction between CPILE-a and -actin. The interchain contact pattern of CPILE-a and -
actin was quite similar to the interaction between CPILE-a and -actin. However, it should be 
noted that results from the Contact calculation showed that loop II of CPILE-a did not 
interact with -actin nor with -actin.  
 
Table 9: The interchain contact of CPILE-a--actin and CPILE-a--actin using the Contact 
program in CCP4. 
CPILE-a--actin CPILE-a--actin 
 CPILE-a -actin  CPILE-a -actin 
Loop I L61 
D62 
N63 
E65 
E276, N280 
K284 
K284, M283, N280 
M283, R290, Y279 
Loop I L61 
D62 
N63 
E65 
N280, C272 
K284 
N280, M283, K284 
M283 
Loop II - - Loop II - - 
PT I N267 T66 PT I - - 
Loop III P301 
L308 
Y313 
E270 
E270, G268, M269 
E270 
Loop III G300 
P301 
L308 
Y313 
E270 
E270 
G268, E270, M269 
E270 
Loop IV S349 
A350 
F351 
A352 
K353 
R354 
S271, A272, E270, M176 
S271, E270 
E270 
E270, S271, A272 
E270, S271 
E270 
Loop IV S349 
A350 
F351 
A352 
K353 
 
R354 
S271, C272, E270, L176 
S271, E270 
E270 
E270, C272 
E270, S271, C272, P264, 
S265 
E270 
Loop V - - Loop V E375 
G376 
K113 
K113 
PT II S404 
L405 
E276 
N280, A272, E276, G273, 
PT II S404 
L405 
E276 
E276, C272, E270, N280, 
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G406 
T277 
E276 
G273 
 
Mutational studies of actin binding site in CPILE-a and Ia 
The sequence and structural alignment of CPILE-a and Ia showed a conserved triad 
motif. This finding indicated that CPILE-a might be capable of ADP-ribosylation at Arg177 
of G-actin, as Ia did. According to the structure comparison of CPILE-a and Ia, CPILE-a 
might have ADP-ribosyltransferase activity similar to that of Ia. However, we do not know 
which interactions with actin are important. Thus, we selected 12 amino acid residues of 
CPILE-a and mutated them to study the effect of those mutants on ADP-ribosyltransferase 
activity (Figure 31). Moreover, nine residues of Ia were also selected to mutate and undergo 
further study. 
 
 
Figure 31: Actin interaction sites of CPILE-a and Ia. The amino acid residues of interest were selected 
for the mutational study. The side chain of Glu-270A of -actin is shown as a sphere in Ia.  
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The amino acids of interest were Leu61, Asn63 from loop I, Tyr252 from loop II, 
Leu308, Tyr313 from loop III, Lys353 from loop IV, and Tyr377, Glu380, Glu382 from loop 
V. Members of PT I and PT II of CPILE-a, including the double glycine mutants, Glu266, 
Asn267 and Ser404, Leu405 were mutated and studied. The mutants of Ia were selected as 
the similar sites of CPILE-a and included Tyr60 and Tyr62 from loop I; Tyr251 from loop II; 
Leu306 and Tyr311 from loop III; Lys351 from loop IV; and Tyr375, Glu378, and Glu380 
from loop V.  
 
FITC-assay of ADP-ribosyltransferase 
To measure the ADP-ribosyltransferase activity against -actin and -actin, both 
wild-type and mutants of CPILE-a and Ia were detected by using the FITC method (Figure 
32). Briefly, biotin-NAD
+
 interacted with the CPILE-a or Ia active site and was then cleaved 
to nicotinamide and the oxocarbenium cation. Next, the biotin–oxocarbenium ion was 
transferred to -actin or -actin and the biotin-ADP-ribosylated actin was labeled by 
streptavidin-tagged fluorescein. The FITC results showed that wild-type CPILE-a exerted 
ADP-ribosyltransferase activity against-actin and -actin; however, the sensitivity against 
-actin was one third that against -actin. Ia also ADP-ribosylated both actin isoforms. The 
sensitivity against -actin was 55% of the sensitivity against -actin. 
 
 
Figure 32: ADP-ribosylation assay of wild-type CPILE-a and Ia against-actin and -actin. The top 
panel shows FITC-labeled -actin and -actin. The -actin bands are composed of native -actin 
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(above) and protease-cleaved -actin (below). Three independent experiments were performed and the 
error bar represents the S.D.  
  
A comparison among the CPILE-a variants showed that most mutants affected ADP-
ribosyltransferase activity against -actin except for S404A and L405A (Figure 33). The 
ARTase activities of Y252A (loop II) and E266G/N267G (PT I) were drastically decreased 
against -actin. On the other hand, these two mutants showed almost no effect against -
actin. The selected loop III mutants (L308A and Y313A) had moderate effect against -actin 
and less effect against -actin. The K353A mutant from loop IV showed drastically 
decreased ARTase activities against -actin and -actin. Member of loop V influenced 
ARTase activities and had large effects on ARTase activity against -actin. Mutants of 
catalytic glutamate had almost no ARTase activities against both actin isoforms. 
 A comparison of the Ia mutants showed that two mutants from loop I (Tyr60 and 
Tyr62) had large effects on ARTase activity against -actin. Similar trends were found in the 
reaction against -actin, but showed lesser effects. Y251A (loop II) had a large effect on 
both actin isoforms. Mutants from loop III and loop IV had a moderate effect on both actin 
isoforms. Interestingly, mutants from loop V had large effects on ARTase activities against 
-actin and -actin; especially E378S and E380S lost all of their enzyme activities. 
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Figure 33: ADP-ribosylation assay of CPILE-a and Ia against-actin and -actin. Comparison of 
the ADP-ribosylation activity of the wild-type and mutants. The ADP-ribosylation assay was performed by 
using biotin-NAD
+
; then, the biotin-ADP-ribosylated actin was detected by streptavidin-FITC. Three 
independent experiments were performed and the error bar represents the S.D. In α-actin case, two bands 
were observed [α-actin (top) and protease cleaved α-actin (down)]. Thus each FITC- labeled actin from 
two bands are calculated and shown (white: non-cleaved black: cleaved). 
 In comparison with the Ia mutants, the CPILE-a mutants influenced the ARTase 
activities against -actin and -actin; however, they demonstrated different profiles from 
that of Ia. Namely, CPILE-a mutants showed different ARTase activities pattern against -
actin and -actin. They have more sensitivity against -actin than -actin. These FITC 
results suggested that CPILE-a preferred -actin more than -actin as a substrate. 
 
Discussion and Conclusion 
Mutational studies of the actin binding sites in CPILE-a and Ia 
 In this study, FITC results showed differences in sensitivity and patterns between 
CPILE-a and Ia against -actin and -actin. Regarding Ia’s loop I, Tyr60 interacted with 
E276
A
 through an ionic bond, shared a hydrogen bond with N280
A
, and had a large effect on 
ARTase activity against -actin (Tsuge et al., 2008; Tsurumura et al., 2013). CPILE-a 
harbored Leu61 and Asn63 instead of Tyr60 and Tyr62, which suggested a lower binding 
affinity of CPILE-a to actin relative to that of Ia.  
Y252A had a large effect on ARTase activity against -actin similar to that of Y251A 
of Ia (Tsuge et al., 2003). Interestingly, this CPILE-a mutant had little effect against -actin 
in contrast to the large effect of Ia. The role of this tyrosine in Ia and CPILE-a remains 
unknown. It should be noted that Tyr positions on the same α helix 7 (including Asn256), 
which have already been mentioned in the discussion on structural differences between Ia and 
CPILEa, which suggested that this α helix may have an important function for both NAD 
glycohydrolase and ADP-ribosyltransferase. 
The double mutant from PT I showed a different pattern against actin isoforms, which 
indicated its role on -actin recognition. Again, the members of loop III influenced ARTase 
activity against two actin isoforms in Ia. However, it showed a different pattern in CPILE-a. 
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Tsurumura et al., (2013) reported an ionic bond between Tyr311 and actin. However, this 
tyrosine residue seemed to recognize -actin rather than -actin in CPILE-a.  
The mutant from loop IV in CPILE-a showed a large effect against both actin 
isoforms in contrast to Ia, which indicated the important roles of this lysine residue in CPILE-
a, probably on actin binding. Mutants of the catalytic glutamate had large effects on ARTase 
in Ia, similar to the results of previous studies (Tsuge et al., 2003), and in CPILE-a, they also 
showed almost no enzyme activity. However, the E380A of CPILE-a showed some activity 
against both actin isoforms. It was likely that this residue had a different role in the 
interaction between CPILE-a and Ia. According to the CPILE-a-actin model, Tyr377 seems to 
fit the shallow concave area as well as Tyr375 (φ) in the Ia–actin complex crystal structure 
(Toniti et al., 2017). Consequently, Y377A had a larger effect on ARTase activity. Together, 
these FITC results confirmed the important roles of this φ in actin binding. (It will be 
discussed in final discussion). 
 
 
…………………………………… 
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Chapter V 
How does E49R mutation affect ADP-ribosylation in I222 crystal? 
 According to the constructed CPILE-a––actin model and the molecular packing of 
NAD
+
-CPILE-a, Glu49 (E49) was located close to the NAD
+
, and we assumed that it might 
be a ADP-ribose moiety acceptor in the crystal (Figure 33A). Thus, the E49R CPILE-a model 
was constructed (Figure 34B).  
 
Figure 34: Crystal structure of the molecular packing of E49 CPILE-a (A) and model structure of 
E49R CPILE-a (B). A) The crystal structure of interest is colored as the wild type CPILE-a, whereas the 
neighbor molecules are gray colored. The E49 (marine blue) and NAD
+
 are shown in the stick model. B) 
E49R CPILE-a of interest is colored as shown in A), whereas neighbor molecules are gray colored. NAD
+
 
is shown in the stick model. E49R is shown as the red stick. 
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To prove this hypothesis, the Glu49 residue was mutated to arginine. The E49R cpile-
a/pGEX4T-2 was expressed and purified by following the same protocol as used for the wild-
type and all CPILE-a mutants. The expression level and purity of E49R CPILE-a were not 
different from those of the wild-type CPILE-a.  
First we checked that the FITC experiment failed to prove the hypothesis in solution 
(data not shown) and then we tried to see whether it possesses ADP-ribosylation activity on 
the adjacent molecule in the I222 crystal. Thus, the E49R CPILE-a purified was subjected to 
co-crystallization with 10 mM NAD
+
 under the same conditions as those for the wild-type 
CPILE-a. Then, the selected trapezoidal-shaped crystals were picked up and soaked in 10 
mM NAD
+
 solution for 22 hours. The data set was collected at BL5A at the KEK Photon 
Factory (Table 10).  
 
Table 10: Data collection of E49R. 
Data collection E49R CPILE-a 
Space group I222 
Cell dimensions  
a, b, c (Å) 70.1, 96.1, 125.2 
a, b, g (°) 90.0, 90.0, 90.0 
X-ray source BL5A 
Wavelength (Å) 1.0000 
Resolution range (Å) 50.00-1.90 (1.93-1.90) 
Observed reflections 200627 
Rmeas
a
 0.113 (0.939) 
Rpim
b
 0.045 (0.474) 
CC1/2
c
 (0.799) 
I / σI (%) 15.35 (0.82) 
Completeness (%) 98.0 (72.8) 
Redundancy 5.9 (3.3) 
aRmeas = ∑ {𝑁(ℎ𝑘𝑙) [𝑁(ℎ𝑘𝑙) − 1]⁄ }
1
2ℎ𝑘𝑙 ∑ |𝐼𝑖(ℎ𝑘𝑙) − 〈𝐼(ℎ𝑘𝑙)〉|𝑖 ∑ ∑ 𝐼𝑖(ℎ𝑘𝑙)𝑖ℎ𝑘𝑙⁄ , 
bRpim = ∑ {1 [𝑁(ℎ𝑘𝑙) − 1]⁄ }
1
2ℎ𝑘𝑙 ∑ |𝐼𝑖(ℎ𝑘𝑙) − 〈𝐼(ℎ𝑘𝑙)〉|𝑖 ∑ ∑ 𝐼𝑖(ℎ𝑘𝑙)𝑖ℎ𝑘𝑙⁄ , where    𝐼𝑖(ℎ𝑘𝑙) are the observed intensities, 
〈𝐼(ℎ𝑘𝑙)〉 is the average intensity and 𝑁(ℎ𝑘𝑙) is the multiplicity of reflection ℎ𝑘𝑙. 
cCC1/2 = percentage of correlation between intensities from random hkl-data sets
 
 
The E49R CPILE-a structure was solved at 1.88 Å by MR using 5WTZ as a search 
model. The E49R CPILE-a crystal structure belongs to a member of the I222 space group and 
consists of one molecule in an asymmetric unit. 
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Table 11: Refinement statistics of E49R. 
Refinement E49R CPILE-a 
Resolution (Å) 1.885 
Rwork/Rfree
a
 (%) 19.5 / 26.1 
r.m.s.deviations  
Bond lengths (Å) 0.007 
Bond angles (°) 1.018 
Ramachandran plot   
Favored regions (%) 95.43 
Allowed regions (%) 4.09 
Outliers (%) 0.48 
PDB ID - 
aRwork = ∑ ||𝐹𝑜𝑏𝑠| − |𝐹𝑐𝑎𝑙𝑐||ℎ𝑘𝑙 ∑ |𝐹𝑜𝑏𝑠|ℎ𝑘𝑙⁄ . Rfree is the cross-validation R factor for the test set (5%) of reflections  
omitted from model refinement. 
 
The overall structure of E49R CPILE-a was not much different from the template at 
RMSD 0.149 for 359 amino acid residues (Figure 35). The NAD
+
 of both structure fit to the 
NAD cleft in the same configuration. The Ramachandran outliers of the E49R CPILE-a were 
Ala11 and Glu215 the same as 5WTZ.  
 
 
Figure 35: Superimposed structure of 5WTZ and E49R CPILE-a. 5WTZ is shown in gray, whereas 
E49R CPILE-a is in cyan. The NAD
+
 fits in the NAD cleft. The E49R mutant is shown in the stick model 
(red circle).  
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The crystal structure demonstrated that there was no evidence of ADP-ribosylation of 
the adjacent Arg49 residue even if they were close enough to transfer the ADP-ribose moiety 
(Figure 36). The Arg49 of interest shared hydrogen bonds with O2 and NC1 of the 
neighboring NAD
+
 at distances of 3.66 Å and 3.81 Å, respectively. Moreover, the Arg49 of 
interest shared another hydrogen bond with the water molecule nearby. Again, the expansion 
of the cell symmetry confirmed the FITC result that E49R CPILE-a failed to transfer the 
ADP-ribose to the adjacent molecule.  
 
 
Figure 36: Structures of E49R CPILE-a and the adjacent NAD
+
 molecule. The electron density maps 
of E49R CPILE-a are set at 2Fo-2Fc = 1.00 and Fo-Fc = 3.05 rmsd, respectively.  
 
Figure 37 shows a representation of the molecular packing of E49R CPILE-a. The 
structure of E49R CPILE-a of interest is located at the center. This structure is represented by 
the same color as that used for the wild-type CPILE-a. Marine blue represents the N-terminal 
domain and yellow represents the C-terminal domain. The neighboring structure is shown in 
purple. The crystal structure shows the close contact between E49R and the NAD
+
 of the 
neighbor. 
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Figure 37: Crystal structure of the molecular packing of E49R CPILE-a. The crystal structure of 
interest is colored as the wild-type CPILE-a, whereas neighbor molecules are purple colored. NAD
+
 is 
shown in the stick model. E49R is shown as a red stick. 
 
Discussion and Conclusion 
E49R as a model of ADP-ribosylation in the I222 crystal 
Even though E49R CPILE-a failed to transfer the ADP-ribose to the adjacent 
molecule, the ARTase activity against actin was not affected by the E49R mutant. This 
mutant showed activities against -actin and -actin similar to the wild-type. Moreover, the 
E49R crystal structure was not much different from the wild-type. On the basis of the FITC 
results and the crystal structure of E49R CPILE-a, we concluded that E49R CPILE-a failed to 
transfer the ADP-ribose to the adjacent molecule. This topic will be further discussed in 
chapter VI. 
 
 
…………………………………… 
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Chapter VI 
Final discussion and Conclusion 
Structural comparison of CPILE-a and Ia 
Recently, the newly discovered enterotoxins were studied by two different groups and 
named binary enterotoxin of C. perfringens (BEC) and C. perfringens iota-like enterotoxin 
(CPILE), respectively (Yonogi et al., 2014; Monma et al., 2015; Irikura et al., 2015). It 
should be noted that CPILE (Monma’s group) was presented at the 87th Annual Meeting of 
the Japanese Society for Bacteriology in 2013 and the 8
th
 International Conference on the 
Molecular Biology and Pathogenesis of the Clostridia-ClostPath in the same year. In addition, 
BEC was studied by Yonogi’s group, and some characteristics of BECa and BECb were 
published in 2014. However, the results of a BLAST search indicated that the sequences of 
cpile and bec matched. This BLAST result indicated that CPILE and BEC were identical 
toxins (Irikura et al., 2015). Our CPILE-a structures (apo-CPILE-a, NAD
+
-CPILE-a, and 
NADH-CPILE-a) were compared with the crystal structures of apo-BECa and NADH-BECa 
that had been published by Yonogi’s group recently (Kawahara et al., 2016).  
Among all of the structures compared, only that of NADH-BECa (5H04) showed a 
large conformational change in the ARTT loop: the Tyr377 on the ARTT loop pointed away 
from the NAD binding cleft (Figure 38 and Table 12), which indicates the flexibility of the 
ARTT loop rather than of the natural structure. However, this flexibility of the ARTT loop 
did not seem to reflect the actin complex structure. The Tyr377 of the ARTT loop was 
thought to be an important residue in complex formation with actin, as described below. 
 
Figure 38: Graphic structure of the ARTT loops of 5WU0 (yellow) and 5H04 (gray). Tyr377 of BECa 
is 15.3 Å away from the same residue of CPILE-a. 
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Table 12: Structural comparison between CPILE-a and BECa (focus on the ARTT loop; V373-E380). 
Source: Toniti et al., (2017).  
 5GTT 5WTZ 5WU0 5H03 5H04 
5GTT -     
5WTZ 0.38 (6) -    
5WU0 0.58 (7) 0.20 (8) -   
5H03 0.76 (8) 1.31 (8) 1.35 (8) -  
5H04 3.02 (8) 2.74 (8) 2.68 (8) 3.28 (8) - 
RMSD (Å) and number of the Cα compared in the parenthesis. 
5GTT: apo-CPILE-a, 5WTZ: NAD+-CPILE-a, 5WU0: NADH-CPILE-a, 5H03: apo-BECa, 5H04: NADH-
BECa 
 
φ Convex–concave interaction on the ARTT-loop 
The crucial role of the bipartite ADP-ribosylating toxin turn-turn (ARTT) motif on 
substrate amino acid recognition of C3 exoenzyme was proposed by Han et al. (2001). The 
consensus sequence for the ARTT motif is φ X-X-(E/Q)-X-E, where φ represents an aromatic 
residue and has a role in substrate selection (Han et al., 2001). Moreover, the E/Q on the 
second loop is important for target residue recognition.  
 
 
Figure 39: Convex–concave in focus. A) Model structure of CPILE-a-actin complex (CPILE-a; yellow, 
actin; green, Ia; gray). B) Complex structure of C3 Exoenzyme-RhoA (C3; Aquamarine, RhoA; Oranges). 
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In comparison with Tyr375 of Ia, the Tyr377 CPILE-a was positioned above the shallow 
concave area involving Leu110
A
, Arg177
A
, Ile75
A
, and Pro112
A
 (Figure 39A). This Tyr377 
should be a positional change upon actin binding. In C3 exoenzyme, the Tyr180 of C3 points 
toward the deep convex area of RhoA adjacent to the Asn41 (Figure 39B). Based on the 
mutagenesis of this study, it was concluded that the φ convex–concave interaction is one of 
the most important interactions required for formation of a complex with actin.  
 
ADP-ribosyltransferase substrate recognition 
 The ADP-ribosyltransferase substrate recognition can be categorized into two 
concepts: protein–protein selection and protein–substrate amino acid recognition. The classic 
examples in ARTC members carry the RSE triad motif: CPILE-a/Ia ADP-ribosylates actin at 
Arg177 and C3 ADP-ribosylates RhoA at Asn41. In protein–protein selection, each toxin 
selects actin and RhoA as a protein substrate, respectively. How CPILE-a/Ia selects its 
protein substrate can be explained by the structure analysis of the Ia–actin complex and the 
mutagenesis studies of CPILE-a and Ia in this study.  
As mentioned previously, the φ convex–concave interaction on the ARTT loop is one 
of the major interactions for substrate binding. However, it remains unclear how CPILE-a 
and Ia distinguish between α-actin and β/γ-actin. More complex structural analysis of, e.g., 
CPILE-a–actin, may lead to better understanding of this phenomenon. On the other hand, the 
C3–RhoA complex structure revealed that C3 recognized RhoA via switch I, switch II, and 
interswitch regions (Toda et al., 2015),and they also succeed in making the Cdc2 mutant an 
active substrate, as determined from structural information.  
In protein–substrate amino acid recognition, each toxin recognizes arginine and 
asparagine as separate targets of ADP-ribosylation. The ARTT loop is located in one of the 
conserved triad motifs, the Q/EXE motif. It has been proposed that the first glutamine (C3) or 
glutamate (CPILE-a/Ia) is a key amino acid residue that is crucial for selecting and 
recognizing the target residue (Han et al., 2001). The role of this residue on target amino acid 
residues has been studied for a long time but it has not been confirmed directly (Cassel and 
Pfeuffer, 1978; Iglewski et al., 1978; Aktories et al., 1986; Maehama, Hoshino, and Katada, 
1996; Han et al., 1999; Han et al., 2001; Hochmann et al., 2006; Margarit et al., 2006; 
Vogelsgesang and Aktories, 2006; Tsuge et al., 2008).  
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In 2006, Vogelsgesang and Aktories reported that the Q217E exoenzyme C3 (EXE 
C3) of Clostridium limosum failed to modify its natural substrates, RhoA or poly-L-
asparagine. On the other hand, it turned to be an arginine–modifying enzyme. This EXE-
C3lim modified poly-L-arginine and soybean trypsin inhibitor (SBTI). The SBTI was a 
model substrate for many arginine-specific ADP-ribosyltransferases. They concluded that an 
asparagine-ADP-ribosylating enzyme can be changed into an arginine-modifying transferase 
by exchanging one amino acid residue located in the catalytic site of the ARTT loop. They 
changed asparagine in RhoA to arginine and tested whether EXE-C3 was able to 
modifyAsn41Arg- RhoA, but they found that it did not.  
Recently, the role of glutamine in target recognition has been confirmed by the 
complex structure of C3-RhoA (Toda et al., 2015). They demonstrated that Gln183 of C3cer 
shared hydrogen bonding on the Asn41 of RhoA and showed the conformational plasticity of 
the ARTT loop (Toda et al., 2015; Tsuge, Yoshida, Tsurumura, 2015). On the other hand, we 
have no direct evidence of Ia–actin structure (even pre- and post-ADP-ribosylation 
structures), but we expect that there should be such interaction in an intermediate structure of 
ADP-ribosylation (Figure 40). 
 
 
Figure 40: Mechanism of substrate recognition of the ADP-ribosylating toxins. The proposed 
interaction between Glu378 of Ia and Arg177 of actin is shown on the left. The interaction between 
Gln183 of C3 and Asn41 of RhoA is shown on the right. Modified from Tsuge et al., 2016. 
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The Q/EXE motif is found in all known bacterial arginine-, cysteine-, asparagine-, 
and guanosine-specific ARTs (Hottiger et al., 2010). Although we did not succeed in creating 
a model of E49R in the crystal experiment, this type of study highlights to the key factors in 
amino acid substrate recognition of the ADP-ribosylating toxins. 
In conclusion, CPILE-a harbored the highly conserved RSE triad motif similar to that 
of the other members of ARTC toxins. The apo-, NAD
+
-, and NADH-CPILE-a crystal 
structures were studied and deposited in PDB as 5GTT, 5WTZ, and 5WU0, respectively. 
Even though CPILE-a and Ia had similar tertiary structures, they had different NAD 
glycohydrolase activities. CPILE-a had almost no NAD glycohydrolase activity without actin 
and showed an unknown activity with actin. This difference might be caused by one α helix 
position forming the narrow NAD binding cleft without actin.  
Actin may induce some change in the NAD binding pocket and induce an unknown 
reaction. Enzyme activity modulation by other protein can be seen as in next example. 
Without α-lactalbumin, β-1, 4-galactosyltransferase transfers UDP-galactose to terminal 
GlcNAc. With α-lactalbumin, this enzyme changes its acceptor from GlcNAc to D-glucose 
and catalyzes lactose synthesis (Richardson and Brew, 1980). However, we do not deny the 
possibility that the unknown product was produced from ADP-ribosylated actin.  
Moreover, CPILE-a possessed ADP-ribosyltransferase activity against both α-actin 
and β/γ-actin, but it showed different sensitivity against actin isoforms. CPILE-a preferred α-
actin as a substrate more than β/γ-actin. However, it is still unclear how CPILE-a and Ia 
distinguish between α-actin and β/γ-actin. In the near future, the complex structure of CPILE-
a-actin might provide information useful for substrate selection and recognition of ADP-
ribosylating toxins. 
 
 
……………………………………  
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Summary 
 
A novel enterotoxin produced by Clostridium perfringens was isolated from several 
food poisoning outbreaks in Japan between 1997 and 2010. The clinical features and 
epidemiological investigations provided evidence that those food poisoning outbreaks might 
be caused by C. perfringens even though the cpe or CPE had not been detected. The isolates 
were identified as C. perfringens type A because the lethal activity was neutralized by anti-
alpha toxin serum and carried on the alpha-toxin gene.  
 The CPILE in the present study belonged to the W5052 strain, which was isolated 
from the outbreak in Tokyo. CPILE-a shared high sequence similarity to Ia (62%); hence, this 
study focused on the similarities and differences between CPILE-a and Ia on structural and 
functional aspects. The crystal structure of CPILE-a is similar to Ia with an RMSD 1.56 Å 
(360 amino acid residues compared), but it has some extra-long loops not present in Ia. The 
different loops are loop I (Ala60-Ile67), protruding loop I (PT I; Gly262-Ser269), and 
protruding loop II (PT II; Glu402-Lys408). The RSE triad motifs are perfectly conserved in 
CPILE-a. 
Examination of the crystal structures of NAD
+
-CPILE-a (5WTZ) and CPILE-a-
NADH (5WU0) showed that there were no obvious structural differences between them. On 
the other hand, CPILE-a has a narrower NAD-binding pocket than that of Ia. NADase 
activity is different between CPILE-a and Ia. Our NADase assay showed that CPILE-a had 
almost no NADase activity even incubated at room temperature overnight, whereas Ia 
showed high NADase activity. Interestingly, the NADase activity with actin results 
demonstrated that actin seemed to trigger an unknown reaction of CPILE-a and produced 
unidentified products at chromatographic retention times of 1.4 minutes and 3.0 minutes. 
These differences might be brought by narrow NAD-binding pocket of CPILE-a. 
Furthermore, several important amino acid residues were selected and mutated to 
study the interaction between CPILE-a and actin by using the FITC technique. The results 
showed that the CPILE-a mutants had different patterns of ADP-ribosyltransferase activity 
between -actin and -actin. However, the Ia mutants influenced the ADP-
ribosyltransferase activity against muscle -actin in a manner similar to that against non-
muscle -actin. Wild-type CPILE-a preferred -actin as a substrate more than -actin. It 
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remains unclear how CPILE-a interacts and distinguishes particular actin isoforms that have 
only twenty seven amino acid residue differences between -actin and -actin.  
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Chapter VII 
Materials and Methods 
Protein expression and purification 
A) CPILE-a 
The cpile-a/pGEX4T-2 vectors that expressed a glutathione S-transferase (GST) with 
a thrombin site at the amino-termini were transformed into E. coli BL21 (DE3)-competent 
cells. Then, the activated competent cells were spread on LB agar containing ampicillin and 
were incubated at 37°C overnight. A single colony was picked up and inoculated into LB 
broth containing 100 µg/ml ampicillin. Those cells were grown overnight at 37°C with 150 
rpm shaking.  
The overnight culture was inoculated into 1.5 L of LB broth containing 100 µg/ml 
ampicillin. The culture broth was allowed to grow until the absorbance at 600 nm reached 0.6, 
then the final concentration of 1 mM of isopropyl β-D-1-thiogalactopyranoside (IPTG) was 
added. For the induction period, the culture cells were incubated at 16°C with 100 rpm 
shaking overnight and were harvested by centrifugation at 8,000 x g at 4°C for 5 minutes.  
CPILE-a protein were extracted by using the Bugbuster protein extraction reagent 
(Novagen) and then were centrifuged at 13,000 rpm, at 4°C for 35 minutes. Then, the 
supernatant was passed through GSH Sepharose 4B beads (GE Healthcare). The beads were 
washed with 50 ml of phosphate buffer saline (PBS), pH 7.4, then thrombin was added to the 
Sepharose beads, and the suspension was incubated at room temperature overnight.  
The day after, CPILE-a was eluted by using PBS, and the protein concentrations of 
every milliliter of the eluent were checked by using NanoDrop. The eluents were further 
purified by gel filtration chromatography using a Superdex 200 column (GE Healthcare). The 
purity of CPILE-a was checked by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) at 
47.5 kDa band.  
In addition, selenomethionine-labeled CPILE-a, triple cysteine mutants CPILE-a, and 
12 mutants were expressed and purified in the manner as used for the wild-type. The 12 
mutants of CPILE-a were L61A, N63A, Y252A, L308A, Y313A, K353A, Y377A, E380A, 
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E382A, S404A, L405A, and a double mutant E266G/N267G. To avoid a freeze-thaw cycle, 
the purified CPILE-a mutants were aliquoted and kept at –80°C until used. 
B) Ia 
The Ia/pET15b vectors that expressed His6-tag that included a thrombin site in the 
amino-termini were transformed into E. coli BL21 (DE3) competent cells. The E. coli 
culturing was performed as described above.  
The cell paste was resuspended in A-buffer containing 20 mM Tris HCl, 500 mM 
NaCl, and 20 mM imidazole at pH 8.0. Then, the cell suspension was lysed by sonication and 
centrifuged at 13,000 rpm for 35 minutes at 4°C. The supernatant was passed through Ni-
NTA resin (Thermo Fisher Scientific). The resins were washed in 50 ml of A-buffer, then 
thrombin was added and the suspension was incubated at room temperature overnight. Ia was 
eluted by using the A-buffer and further passed through a first PD10. Then, the eluents were 
injected into a UNO-Q1 and subjected to a second PD10 before further purification by gel 
filtration chromatography using a Superdex 75 column (GE Healthcare). Nine mutants of Ia, 
including Y60S, Y62S, Y251A, L306S, Y311S, K351S, Y375S, E378S, and E380S, were 
expressed and purified in the same as used for the wild-type. 
 
Crystallization and structure determination 
Crystallization of the purified CPILE-a was attempted by using a variety of protein 
concentrations and two Hampton screening kits, including HR2-110 and HR2-112. After 
several tries, the crystals formed in the drop from the HR2-110 screening kit #6. Several 
buffers, salts, pHs, PEG concentrations, and temperatures were also screened. Interestingly, 
CPILE-a crystals only grew under MgCl2 salt alkaline conditions.  
Finally, the CPILE-a crystals were grown at 4°C via hanging drop vapor diffusion 
against a reservoir containing 18% PEG4000 and 100 mM Tris HCl at pH 8.5in 200 mM 
MgCl2. The drop carried equal volumes of the purified CPILE-a and reservoir solution. The 
selected crystal was flash-frozen in liquid nitrogen with 30% ethylene glycol as a 
cryoprotectant; then, the data sets were collected in-house by using a MicroMax-007 
generator and RAXIS VII (RIGAKU) at 2.01 Å. All diffraction images were processed by 
HKL2000 suite.  
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However, the first attempt to determine the CPILE-a structure by molecular 
replacement (MR)  failed to solve the structure even though the Ia structure (1GIQ) was used 
as a search model. The second attempt using a selenomethionine-labeled data set also was 
unsuccessful in solving the phase determination problem. Thus, the triple mutants of cysteine 
substitution to Ala97, Ser185, and Ser366 were introduced to obtain the phase by using heavy 
atom replacement. The crystals were soaked in 1 mM mercury chloride mother liquor for 22 
hours, then the data sets at three different wavelengths for peak, edge, and remote were 
collected by using an NW-12A beamline in KEK PF-AR.  
The initial phase was obtained by using SHELX (hkl2map). Next, auto-tracing with 
side-chain information was performed by using ARP/wARP. The structure was refined by 
using phenix.refine and the PDB_REDO Web server. Finally, the space group of I222 at cell 
dimensions of a = 70.338 Å, b =100.665 Å, and c = 126.003 Å was refined against the wild-
type CPILE-a data obtained earlier in-house at 2.01 Å resolution. 
 
Molecular modeling of actin–CPILE-a 
The alpha actin- and beta actin-CPILE-a complexes were modeled by using the Ia–
actin complex (4H03) and profilin-beta actin complex (2BTF). The complex models were 
obtained by using LSQ superpose in the CCP4i suite, and then the complex structure was 
featured by using PyMOL. The models were subjected to energy minimization by using 
UCSF Chimera. This energy minimization consists of steepest descent and conjugate gradient 
methods for finding a minimum on the potential energy of the complex. The complex models 
were screened for all interchain contact residues by using the Contact program in the CCP4i 
suite at distances < 5 Å.  
 
Mutagenesis and ADP-ribosyltransferase activity assay 
For the actin–CPILE-a model, 11 residues were selected to substitute with alanine. 
The mutants were L61A, N63A (loop I), Y252A, L308A, Y313A (loop III), K353A (loop IV), 
Y377A, E380A, E382A (loop V), S404A, and L405A (protruding loop II). Moreover, the 
double glycine substitution was made as E266GN267G (Protruding loop I). After purification, 
the mutants were tested for ADP-ribosyltransferase activity by using fluorescein 
isothiocyanate (FITC) labeling as a part of the streptavidin-biotin complex. Briefly, biotin-
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NAD was cleaved and the biotin-ADP-ribose moiety was transferred to the target actin; 
hence, the ribosylated actin was labeled by streptavidin-FITC. The FITC labeling was 
detected by Typhoon FLA 9000 (GE Healthcare) at 800 V.  
 
NADase activity 
 The reaction compoments were 10 μM enzyme (CPILE-a or Ia) and 1 mM βNAD+ in 
20 mM Tris HCl at pH 8.0. The reactions were stopped by freezing at –80°C for 2 minutes. 
The mixtures were thawed and injected into an LC Net II/ADC Chromatography Data 
Solutions system (JASCO), which was equilibrated with a mobile phase composed of a 
mixture of 20 mM phosphate buffer, pH 5.9, and 5% (v/v) acetonitrile. The reference 
substances included βNAD+, βNADH, nicotinamide, ADP-ribose, and AMP. All reference 
substances were prepared as 1 mM and were injected separately. The retention times were 
recorded for 10 minutes. To minimize noise, the column was washed with one volume of 
mobile phase. A similar assay with 10 μM actin was also performed.  
 
 
…………………………………… 
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Appendix A 
Summary of data collection 
Wild type CPILE-a:  
Summary of reflections intensities and R-factors by shells 
     R linear = SUM ( ABS(I - <I>)) / SUM (I) 
     R square = SUM ( (I - <I>) ** 2) / SUM (I ** 2) 
     Chi**2   = SUM ( (I - <I>) ** 2) / (Error ** 2 * N / (N-1) ) ) 
     In all sums single measurements are excluded 
Shell  
limit 
Lower Upper Average Average Norm. Linear Square  
Angstrom I error Stat. Chi**2 R-fac R-fac Rmeas Rpim CC1/2 CC* 
50.00 
5.45 
4.33 
3.78 
3.44 
3.19 
3.00 
2.85 
2.73 
2.62 
2.53 
2.45 
2.38 
2.32 
2.26 
2.21 
2.17 
2.12 
2.08 
2.04 
5.45 
4.33 
3.78 
3.44 
3.19 
3.00 
2.85 
2.73 
2.62 
2.53 
2.45 
2.38 
2.32 
2.26 
2.21 
2.17 
2.12 
2.08 
2.04 
2.01 
957.2 
1012.5 
941.1 
650.6 
420.3 
273.5 
197.0 
144.7 
101.2 
88.5 
77.7 
67.0 
58.2 
52.0 
46.2 
39.3 
33.8 
30.9 
27.5 
21.3 
14.0 
14.9 
14.8 
12.4 
10.2 
8.6 
7.8 
7.2 
6.8 
6.7 
6.6 
6.6 
6.6 
6.7 
6.8 
7.0 
7.3 
7.4 
7.4 
7.4 
6.7 
8.0 
8.9 
8.7 
8.1 
7.4 
7.0 
6.7 
6.5 
6.5 
6.5 
6.4 
6.5 
6.6 
6.7 
7.0 
7.2 
7.3 
7.4 
7.3 
1.833 
2.695 
3.430 
3.510 
3.346 
3.038 
2.957 
2.606 
2.481 
2.346 
2.235 
2.214 
2.133 
2.089 
2.131 
2.078 
1.965 
1.926 
1.870 
1.869 
0.032 
0.044 
0.054 
0.069 
0.087 
0.109 
0.135 
0.163 
0.213 
0.234 
0.255 
0.283 
0.317 
0.340 
0.362 
0.407 
0.440 
0.455 
0.485 
0.603 
0.032 
0.047 
0.053 
0.064 
0.078 
0.091 
0.109 
0.128 
0.173 
0.181 
0.193 
0.222 
0.231 
0.259 
0.273 
0.347 
0.329 
0.344 
0.358 
0.453 
0.035 
0.048 
0.058 
0.074 
0.094 
0.117 
0.146 
0.176 
0.229 
0.252 
0.275 
0.305 
0.343 
0.369 
0.393 
0.443 
0.480 
0.497 
0.530 
0.660 
0.013 
0.018 
0.021 
0.027 
0.035 
0.043 
0.054 
0.065 
0.085 
0.094 
0.102 
0.114 
0.130 
0.141 
0.152 
0.172 
0.187 
0.195 
0.209 
0.262 
0.999 
0.999 
0.999 
0.997 
0.997 
0.996 
0.994 
0.991 
0.985 
0.983 
0.983 
0.975 
0.975 
0.964 
0.956 
0.947 
0.942 
0.926 
0.924 
0.885 
1.000 
1.000 
1.000 
0.999 
0.999 
0.999 
0.998 
0.998 
0.996 
0.996 
0.996 
0.994 
0.994 
0.991 
0.989 
0.986 
0.985 
0.981 
0.980 
0.969 
All reflections 271.7 8.7 7.2 2.493 0.092 0.059 0.099 0.037   
 
Shell I/Sigma in resolution shells: 
Lower 
limit 
Upper 
limit 
% of of reflections with I / Sigma less than 
0 1 2 3 5 10 20 >20 total 
50.00 
5.45 
4.33 
3.78 
3.44 
3.19 
3.00 
2.85 
2.73 
2.62 
2.53 
2.45 
2.38 
2.32 
2.26 
2.21 
2.17 
2.12 
2.08 
2.04 
5.45 
4.33 
3.78 
3.44 
3.19 
3.00 
2.85 
2.73 
2.62 
2.53 
2.45 
2.38 
2.32 
2.26 
2.21 
2.17 
2.12 
2.08 
2.04 
2.01 
0.4 
0.3 
0.3 
0.3 
1.1 
1.4 
3.0 
2.6 
4.2 
5.6 
5.0 
7.7 
9.2 
9.1 
11.9 
11.6 
15.0 
15.0 
15.3 
16.9 
0.9 
0.6 
1.0 
0.9 
2.8 
4.2 
5.8 
6.6 
10.7 
12.4 
13.2 
16.7 
20.8 
20.5 
26.3 
26.6 
30.0 
30.6 
31.2 
32.9 
1.2 
1.2 
1.8 
2.3 
4.9 
6.6 
10.7 
12.3 
17.1 
20.9 
23.8 
28.0 
31.7 
34.1 
40.5 
39.8 
44.9 
44.8 
46.2 
45.9 
1.7 
2.2 
2.4 
3.7 
7.6 
10.3 
14.5 
17.8 
24.8 
29.0 
33.2 
36.9 
41.2 
44.6 
49.9 
50.2 
56.2 
55.4 
56.4 
56.1 
3.1 
2.9 
3.9 
6.3 
12.5 
16.1 
23.4 
27.1 
35.5 
41.2 
47.6 
49.7 
55.2 
59.7 
62.9 
64.6 
68.1 
68.4 
69.1 
68.2 
5.4 
6.4 
8.4 
13.4 
22.5 
30.5 
37.3 
45.2 
55.2 
59.2 
63.9 
67.7 
72.3 
74.8 
76.4 
81.0 
82.8 
82.4 
79.6 
78.9 
10.6 
12.2 
15.7 
24.0 
38.1 
49.2 
57.5 
65.6 
74.8 
78.9 
81.3 
84.0 
88.0 
89.2 
89.7 
92.4 
93.1 
90.4 
86.3 
83.9 
87.6 
87.8 
84.3 
76.0 
61.9 
50.8 
42.5 
34.4 
25.2 
21.1 
18.7 
16.0 
12.0 
10.6 
9.7 
6.2 
4.5 
4.7 
3.9 
1.8 
98.2 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
99.9 
99.5 
98.7 
97.6 
95.0 
90.2 
85.8 
All hkl 6.7 14.6 22.7 29.4 38.9 51.7 64.7 33.5 98.3 
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Shell Summary of observation redundancies: 
Lower 
limit 
Upper 
limit 
% of reflections with given No. of observations 
0 1 2 3 4 5-6 7-8 9-12 13-19 >19 total 
50.00 
5.45 
4.33 
3.78 
3.44 
3.19 
3.00 
2.85 
2.73 
2.62 
2.53 
2.45 
2.38 
2.32 
2.26 
2.21 
2.17 
2.12 
2.08 
2.04 
5.45 
4.33 
3.78 
3.44 
3.19 
3.00 
2.85 
2.73 
2.62 
2.53 
2.45 
2.38 
2.32 
2.26 
2.21 
2.17 
2.12 
2.08 
2.04 
2.01 
1.8 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.1 
0.5 
1.3 
2.4 
5.0 
9.8 
14.2 
0.4 
0.0 
0.0 
0.0 
0.0 
0.1 
0.1 
0.0 
0.1 
0.0 
0.0 
0.1 
0.3 
0.5 
1.7 
4.1 
7.3 
9.3 
10.2 
11.8 
1.8 
1.0 
1.0 
0.9 
0.9 
0.8 
0.9 
0.8 
0.9 
0.7 
1.1 
1.1 
1.7 
2.5 
4.2 
4.9 
6.5 
7.4 
7.4 
7.2 
2.5 
0.9 
0.9 
1.1 
1.2 
0.8 
0.7 
0.9 
1.1 
0.9 
0.9 
1.4 
1.6 
3.2 
4.8 
5.4 
5.5 
4.8 
5.7 
5.5 
17.8 
12.8 
11.3 
9.8 
10.1 
9.8 
10.5 
9.6 
10.0 
10.4 
10.6 
10.5 
12.0 
12.4 
14.0 
13.7 
13.5 
13.5 
12.3 
10.9 
4.3 
5.0 
5.9 
6.5 
7.9 
8.3 
9.3 
9.2 
9.7 
10.5 
11.1 
13.1 
16.4 
19.0 
17.3 
18.1 
16.4 
15.1 
14.2 
13.4 
71.4 
80.3 
80.9 
81.6 
79.9 
80.2 
78.5 
79.6 
78.4 
77.4 
76.4 
73.9 
68.0 
62.2 
57.4 
52.4 
48.3 
45.1 
40.4 
37.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
98.2 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
99.9 
99.5 
98.7 
97.6 
95.0 
90.2 
85.5 
All hkl 1.7 2.3 2.7 2.5 11.8 11.5 67.6 0.0 0.0 0.0 98.3 
 
Shell  
Average Redundancy Per Shell Lower 
limit 
Upper 
limit 
50.00 
5.45 
4.33 
3.78 
3.44 
3.19 
3.00 
2.85 
2.73 
2.62 
2.53 
2.45 
2.38 
2.32 
2.26 
2.21 
2.17 
2.12 
2.08 
2.04 
5.45 
4.33 
3.78 
3.44 
3.19 
3.00 
2.85 
2.73 
2.62 
2.53 
2.45 
2.38 
2.32 
2.26 
2.21 
2.17 
2.12 
2.08 
2.04 
2.01 
6.8 
7.2 
7.3 
7.3 
7.2 
7.2 
7.2 
7.2 
7.2 
7.1 
7.1 
7.0 
6.8 
6.6 
6.3 
6.1 
5.8 
5.6 
5.4 
5.2 
All hkl 6.7 
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Hg-soaking CPILE-a: 
Summary of reflections intensities and R-factors by shells 
     R linear = SUM ( ABS(I - <I>)) / SUM (I) 
     R square = SUM ( (I - <I>) ** 2) / SUM (I ** 2) 
     Chi**2   = SUM ( (I - <I>) ** 2) / (Error ** 2 * N / (N-1) ) ) 
     In all sums single measurements are excluded 
 
Shell  
limit 
Lower Upper Average Average Norm. Linear Square  
Angstrom I error Stat. Chi**2 R-fac R-fac Rmeas Rpim CC1/2 CC* 
50.00 
5.97 
4.74 
4.14 
3.76 
3.49 
3.29 
3.12 
2.99 
2.87 
2.77 
2.69 
2.61 
2.54 
2.48 
2.42 
2.37 
2.32 
2.28 
2.24 
5.97 
4.74 
4.14 
3.76 
3.49 
3.29 
3.12 
2.99 
2.87 
2.77 
2.69 
2.61 
2.54 
2.48 
2.42 
2.37 
2.32 
2.28 
2.24 
2.20 
627.3 
490.7 
657.5 
540.9 
416.4 
340.4 
225.1 
161.4 
135.4 
102.6 
87.4 
69.9 
62.2 
57.9 
51.6 
48.6 
44.4 
42.4 
38.8 
35.1 
11.0 
9.1 
12.0 
10.8 
9.6 
8.8 
7.3 
6.4 
6.0 
5.6 
5.4 
5.3 
5.2 
5.3 
5.4 
5.5 
5.7 
5.8 
6.0 
6.1 
6.8 
6.3 
8.1 
7.8 
7.5 
7.2 
6.4 
5.8 
5.6 
5.3 
5.1 
5.1 
5.1 
5.2 
5.3 
5.4 
5.6 
5.7 
5.9 
6.0 
2.194 
2.194 
2.162 
2.296 
2.138 
2.049 
1.965 
1.832 
1.811 
1.716 
1.668 
1.585 
1.591 
1.529 
1.494 
1.452 
1.444 
1.453 
1.428 
1.420 
0.040 
0.046 
0.045 
0.054 
0.062 
0.071 
0.089 
0.109 
0.121 
0.149 
0.169 
0.204 
0.229 
0.249 
0.280 
0.301 
0.333 
0.363 
0.400 
0.445 
0.042 
0.048 
0.049 
0.056 
0.060 
0.068 
0.085 
0.101 
0.104 
0.136 
0.153 
0.181 
0.205 
0.223 
0.252 
0.268 
0.288 
0.304 
0.346 
0.406 
0.044 
0.050 
0.050 
0.059 
0.068 
0.077 
0.098 
0.119 
0.133 
0.164 
0.186 
0.224 
0.252 
0.274 
0.309 
0.332 
0.367 
0.400 
0.441 
0.491 
0.018 
0.021 
0.020 
0.024 
0.028 
0.032 
0.040 
0.049 
0.055 
0.068 
0.077 
0.093 
0.105 
0.114 
0.129 
0.138 
0.153 
0.167 
0.185 
0.206 
0.999 
0.998 
0.998 
0.998 
0.997 
0.997 
0.995 
0.994 
0.994 
0.989 
0.987 
0.983 
0.979 
0.976 
0.970 
0.965 
0.965 
0.960 
0.951 
0.927 
1.000 
1.000 
1.000 
0.999 
0.999 
0.999 
0.999 
0.998 
0.999 
0.997 
0.997 
0.996 
0.995 
0.994 
0.992 
0.991 
0.991 
0.990 
0.987 
0.981 
All reflections 211.9 7.1 6.1 1.772 0.089 0.065 0.098 0.041   
 
 
Shell I/Sigma in resolution shells: 
Lower 
limit 
Upper 
limit 
% of reflections with I / Sigma less than 
0 1 2 3 5 10 20 >20 total 
50.00 
5.97 
4.74 
4.14 
3.76 
3.49 
3.29 
3.12 
2.99 
2.87 
2.77 
2.69 
2.61 
2.54 
2.48 
2.42 
2.37 
2.32 
2.28 
2.24 
5.97 
4.74 
4.14 
3.76 
3.49 
3.29 
3.12 
2.99 
2.87 
2.77 
2.69 
2.61 
2.54 
2.48 
2.42 
2.37 
2.32 
2.28 
2.24 
2.20 
0.0 
0.4 
0.5 
0.8 
0.2 
0.4 
1.0 
3.2 
3.2 
3.7 
4.1 
5.2 
4.8 
6.7 
6.5 
7.8 
7.8 
8.1 
9.7 
9.7 
0.0 
0.9 
1.3 
1.3 
0.5 
1.3 
2.7 
5.4 
6.6 
8.6 
8.7 
11.0 
10.8 
13.6 
14.6 
16.9 
18.7 
17.5 
21.3 
21.8 
0.1 
1.3 
1.9 
2.4 
1.4 
2.9 
4.5 
8.2 
10.1 
12.7 
13.9 
17.9 
18.7 
21.3 
23.7 
26.6 
30.7 
28.7 
33.2 
33.7 
0.5 
1.6 
2.6 
3.2 
2.4 
4.4 
6.6 
10.8 
13.6 
16.9 
18.7 
23.9 
24.6 
28.7 
31.4 
35.1 
39.3 
40.0 
44.3 
44.7 
1.8 
2.8 
3.7 
5.3 
5.7 
7.8 
11.3 
15.9 
21.6 
25.9 
27.9 
35.8 
36.1 
39.8 
44.0 
46.7 
51.8 
55.2 
58.6 
59.2 
3.8 
5.5 
6.5 
9.2 
11.9 
15.2 
23.2 
29.5 
36.0 
41.7 
47.2 
54.6 
57.7 
59.4 
64.5 
68.7 
71.3 
74.5 
76.0 
80.1 
8.3 
11.8 
12.8 
18.2 
26.4 
32.4 
42.0 
50.9 
57.1 
64.2 
70.5 
77.3 
81.1 
83.0 
85.8 
87.4 
90.7 
91.4 
93.2 
95.0 
91.4 
88.2 
87.2 
81.8 
73.6 
67.6 
58.0 
49.1 
42.9 
35.8 
29.5 
22.7 
18.9 
17.0 
14.2 
12.6 
9.3 
8.6 
6.8 
5.0 
99.7 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
All hkl 4.2 9.2 14.7 19.7 27.8 41.8 59.0 41.0 100.0 
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Shell Summary of observation redundancies: 
Lower 
limit 
Upper 
limit 
% of reflections with given No. of observations 
0 1 2 3 4 5-6 7-8 9-12 13-19 >19 total 
50.00 
5.97 
4.74 
4.14 
3.76 
3.49 
3.29 
3.12 
2.99 
2.87 
2.77 
2.69 
2.61 
2.54 
2.48 
2.42 
2.37 
2.32 
2.28 
2.24 
5.97 
4.74 
4.14 
3.76 
3.49 
3.29 
3.12 
2.99 
2.87 
2.77 
2.69 
2.61 
2.54 
2.48 
2.42 
2.37 
2.32 
2.28 
2.24 
2.20 
0.3 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.3 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.5 
0.1 
0.1 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.1 
0.4 
0.9 
0.4 
0.5 
0.5 
0.2 
0.1 
0.3 
0.2 
0.3 
0.4 
0.5 
0.2 
0.4 
0.6 
0.8 
0.6 
0.7 
0.5 
1.9 
2.1 
14.9 
12.4 
10.7 
10.8 
11.0 
11.2 
10.9 
11.1 
11.3 
11.6 
11.5 
11.5 
11.7 
12.4 
12.5 
13.2 
13.2 
14.1 
12.7 
14.1 
65.8 
66.6 
66.4 
64.4 
64.6 
62.9 
62.8 
62.5 
61.9 
61.8 
60.8 
61.7 
60.4 
60.0 
59.2 
58.8 
59.8 
57.0 
58.4 
55.9 
17.3 
20.5 
22.3 
24.2 
24.2 
25.8 
25.9 
26.1 
26.5 
26.1 
27.2 
26.6 
27.6 
26.9 
27.5 
27.4 
26.3 
28.3 
26.9 
27.4 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
99.7 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
All hkl 0.0 0.0 0.1 0.6 12.1 61.6 25.5 0.0 0.0 0.0 100.0 
 
 
Shell  
Average Redundancy Per Shell Lower 
limit 
Upper 
limit 
50.00 
5.97 
4.74 
4.14 
3.76 
3.49 
3.29 
3.12 
2.99 
2.87 
2.77 
2.69 
2.61 
2.54 
2.48 
2.42 
2.37 
2.32 
2.28 
2.24 
5.97 
4.74 
4.14 
3.76 
3.49 
3.29 
3.12 
2.99 
2.87 
2.77 
2.69 
2.61 
2.54 
2.48 
2.42 
2.37 
2.32 
2.28 
2.24 
2.20 
5.7 
5.8 
5.8 
5.8 
5.8 
5.8 
5.8 
5.8 
5.8 
5.8 
5.8 
5.8 
5.8 
5.8 
5.8 
5.8 
5.8 
5.8 
5.8 
5.7 
All hkl 5.8 
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Pt-soaking CPILE-a: 
Summary of reflections intensities and R-factors by shells 
     R linear = SUM ( ABS(I - <I>)) / SUM (I) 
     R square = SUM ( (I - <I>) ** 2) / SUM (I ** 2) 
     Chi**2   = SUM ( (I - <I>) ** 2) / (Error ** 2 * N / (N-1) ) ) 
     In all sums single measurements are excluded 
 
Shell  
limit 
Lower Upper Average Average Norm. Linear Square  
Angstrom I error Stat. Chi**2 R-fac R-fac Rmeas Rpim CC1/2 CC* 
50.00 
5.40 
4.29 
3.74 
3.40 
3.16 
2.97 
2.82 
2.70 
2.60 
2.51 
2.43 
2.36 
2.30 
2.24 
2.19 
2.14 
2.10 
2.06 
2.02 
5.40 
4.29 
3.74 
3.40 
3.16 
2.97 
2.82 
2.70 
2.60 
2.51 
2.43 
2.36 
2.30 
2.24 
2.19 
2.14 
2.10 
2.06 
2.02 
1.99 
515.1 
598.3 
525.9 
373.3 
240.8 
152.7 
110.4 
82.7 
61.3 
52.3 
46.3 
39.9 
35.1 
33.4 
28.9 
23.2 
21.3 
19.4 
15.1 
13.2 
8.6 
9.6 
8.8 
6.8 
5.0 
3.8 
3.2 
2.8 
2.6 
2.5 
2.5 
2.5 
2.5 
2.6 
2.6 
2.5 
2.6 
2.6 
2.5 
2.6 
4.9 
5.5 
5.4 
4.6 
3.7 
3.1 
2.7 
2.5 
2.3 
2.3 
2.3 
2.3 
2.4 
2.5 
2.5 
2.5 
2.5 
2.5 
2.5 
2.6 
2.036 
2.130 
2.270 
2.187 
1.977 
1.864 
1.766 
1.662 
1.639 
1.557 
1.551 
1.480 
1.420 
1.572 
1.438 
1.367 
1.356 
1.414 
1.294 
1.230 
0.039 
0.039 
0.043 
0.047 
0.052 
0.061 
0.070 
0.080 
0.099 
0.109 
0.123 
0.137 
0.153 
0.176 
0.193 
0.226 
0.247 
0.273 
0.324 
0.343 
0.047 
0.045 
0.049 
0.050 
0.053 
0.057 
0.063 
0.070 
0.087 
0.089 
0.100 
0.105 
0.118 
0.137 
0.145 
0.167 
0.187 
0.211 
0.227 
0.250 
0.043 
0.043 
0.047 
0.051 
0.057 
0.067 
0.077 
0.088 
0.109 
0.120 
0.136 
0.150 
0.168 
0.193 
0.212 
0.249 
0.272 
0.301 
0.358 
0.382 
0.018 
0.018 
0.019 
0.021 
0.023 
0.027 
0.032 
0.036 
0.045 
0.049 
0.056 
0.062 
0.070 
0.080 
0.088 
0.103 
0.114 
0.126 
0.150 
0.166 
0.998 
0.998 
0.998 
0.998 
0.998 
0.998 
0.997 
0.997 
0.996 
0.995 
0.994 
0.993 
0.992 
0.991 
0.988 
0.984 
0.980 
0.979 
0.971 
0.957 
0.999 
1.000 
1.000 
1.000 
0.999 
1.000 
0.999 
0.999 
0.999 
0.999 
0.998 
0.998 
0.998 
0.998 
0.997 
0.996 
0.995 
0.995 
0.993 
0.989 
All reflections 149.4 4.0 3.1 1.666 0.063 0.051 0.069 0.028   
 
 
Shell I/Sigma in resolution shells: 
Lower 
limit 
Upper 
limit 
% of of reflections with I / Sigma less than 
0 1 2 3 5 10 20 >20 total 
50.00 
5.40 
4.29 
3.74 
3.40 
3.16 
2.97 
2.82 
2.70 
2.60 
2.51 
2.43 
2.36 
2.30 
2.24 
2.19 
2.14 
2.10 
2.06 
2.02 
5.40 
4.29 
3.74 
3.40 
3.16 
2.97 
2.82 
2.70 
2.60 
2.51 
2.43 
2.36 
2.30 
2.24 
2.19 
2.14 
2.10 
2.06 
2.02 
1.99 
0.1 
0.2 
0.6 
0.3 
0.7 
1.9 
3.7 
4.1 
4.7 
5.8 
7.0 
8.0 
8.1 
9.7 
9.1 
11.2 
10.9 
11.1 
15.6 
16.0 
0.3 
0.3 
1.1 
0.6 
1.9 
3.1 
6.1 
8.0 
9.2 
10.5 
13.0 
15.5 
16.5 
19.1 
19.2 
23.1 
23.5 
24.0 
31.8 
33.5 
0.7 
0.6 
1.4 
1.0 
3.3 
4.2 
8.3 
10.9 
13.4 
16.2 
19.3 
22.5 
25.3 
28.3 
29.3 
34.8 
36.0 
38.0 
44.9 
48.3 
0.9 
0.9 
1.7 
1.5 
4.7 
6.0 
11.0 
13.9 
17.1 
21.7 
23.4 
28.9 
32.2 
35.5 
37.1 
44.2 
45.7 
48.5 
54.0 
56.9 
1.3 
1.3 
2.4 
2.4 
7.2 
9.2 
15.4 
19.9 
24.5 
29.7 
32.1 
37.3 
43.4 
46.3 
49.3 
55.9 
57.8 
60.4 
65.1 
68.9 
2.9 
2.7 
4.5 
6.0 
12.8 
16.7 
25.1 
31.6 
40.4 
45.9 
48.9 
54.3 
58.4 
62.3 
65.9 
71.4 
73.0 
77.1 
80.5 
83.7 
5.5 
5.9 
9.8 
14.4 
24.4 
32.6 
42.2 
50.1 
59.2 
64.1 
68.4 
74.4 
77.5 
80.0 
82.3 
87.1 
88.9 
90.6 
93.8 
94.7 
93.8 
94.1 
90.2 
85.6 
75.6 
67.4 
57.8 
49.9 
40.8 
35.9 
31.6 
25.6 
22.5 
20.0 
17.7 
12.9 
11.1 
9.4 
6.2 
5.3 
99.3 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
All hkl 6.4 13.0 19.3 24.3 31.5 43.2 57.3 42.7 100.0 
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Shell Summary of observation redundancies: 
Lower 
limit 
Upper 
limit 
% of reflections with given No. of observations 
0 1 2 3 4 5-6 7-8 9-12 13-19 >19 total 
50.00 
5.40 
4.29 
3.74 
3.40 
3.16 
2.97 
2.82 
2.70 
2.60 
2.51 
2.43 
2.36 
2.30 
2.24 
2.19 
2.14 
2.10 
2.06 
2.02 
5.40 
4.29 
3.74 
3.40 
3.16 
2.97 
2.82 
2.70 
2.60 
2.51 
2.43 
2.36 
2.30 
2.24 
2.19 
2.14 
2.10 
2.06 
2.02 
1.99 
0.7 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.3 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.1 
0.2 
0.8 
0.1 
0.1 
0.1 
0.0 
0.1 
0.0 
0.1 
0.0 
0.0 
0.0 
0.0 
0.1 
0.1 
0.0 
0.0 
0.0 
0.4 
0.6 
1.1 
1.8 
0.7 
0.7 
0.8 
0.6 
0.8 
0.5 
0.8 
0.7 
0.5 
0.6 
0.6 
0.4 
0.9 
0.6 
0.5 
1.0 
1.9 
1.8 
6.1 
17.2 
15.8 
15.8 
15.4 
15.5 
14.8 
15.3 
14.7 
14.6 
14.7 
14.7 
14.9 
14.9 
15.1 
14.5 
15.1 
16.0 
17.5 
18.1 
27.4 
53.6 
55.7 
55.6 
55.6 
55.5 
54.9 
55.0 
55.7 
55.8 
55.1 
55.7 
55.6 
55.6 
55.6 
56.7 
56.0 
56.6 
54.4 
55.0 
47.9 
25.7 
27.7 
27.8 
28.2 
28.4 
29.4 
29.1 
28.7 
28.9 
29.7 
29.0 
29.0 
29.0 
28.3 
28.2 
28.4 
26.5 
25.7 
24.4 
17.4 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
99.3 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
All hkl 0.0 0.0 0.2 1.1 16.1 55.1 27.5 0.0 0.0 0.0 100.0 
 
Shell  
Average Redundancy Per Shell Lower 
limit 
Upper 
limit 
50.00 
5.40 
4.29 
3.74 
3.40 
3.16 
2.97 
2.82 
2.70 
2.60 
2.51 
2.43 
2.36 
2.30 
2.24 
2.19 
2.14 
2.10 
2.06 
2.02 
5.40 
4.29 
3.74 
3.40 
3.16 
2.97 
2.82 
2.70 
2.60 
2.51 
2.43 
2.36 
2.30 
2.24 
2.19 
2.14 
2.10 
2.06 
2.02 
1.99 
5.7 
5.8 
5.8 
5.8 
5.8 
5.8 
5.8 
5.8 
5.8 
5.8 
5.8 
5.8 
5.8 
5.7 
5.7 
5.7 
5.7 
5.6 
5.6 
5.2 
All hkl 5.7 
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NAD
+
-CPILE-a 
Summary of reflections intensities and R-factors by shells 
     R linear = SUM ( ABS(I - <I>)) / SUM (I) 
     R square = SUM ( (I - <I>) ** 2) / SUM (I ** 2) 
     Chi**2   = SUM ( (I - <I>) ** 2) / (Error ** 2 * N / (N-1) ) ) 
     In all sums single measurements are excluded 
 
Shell  
limit 
Lower Upper Average Average Norm. Linear Square  
Angstrom I error Stat. Chi**2 R-fac R-fac Rmeas Rpim CC1/2 CC* 
50.00 
6.78 
5.38 
4.70 
4.27 
3.97 
3.73 
3.55 
3.39 
3.26 
3.15 
3.05 
2.96 
2.89 
2.82 
2.75 
2.69 
2.64 
2.59 
2.54 
6.78 
5.38 
4.70 
4.27 
3.97 
3.73 
3.55 
3.39 
3.26 
3.15 
3.05 
2.96 
2.89 
2.82 
2.75 
2.69 
2.64 
2.59 
2.54 
2.50 
136.6 
53.8 
71.3 
79.4 
64.1 
53.4 
45.7 
35.9 
30.4 
25.5 
17.1 
16.2 
12.3 
11.3 
9.6 
8.4 
6.7 
6.2 
6.7 
5.9 
3.7 
2.3 
2.9 
3.2 
2.8 
2.6 
2.6 
2.4 
2.3 
2.2 
2.0 
2.0 
1.9 
1.9 
1.9 
1.9 
1.9 
1.9 
1.8 
1.8 
3.2 
2.2 
2.7 
3.0 
2.7 
2.5 
2.5 
2.3 
2.2 
2.1 
2.0 
1.9 
1.9 
1.9 
1.9 
1.9 
1.9 
1.9 
1.8 
1.8 
0.471 
0.465 
0.534 
0.634 
0.615 
0.632 
0.663 
0.618 
0.564 
0.571 
0.541 
0.519 
0.516 
0.512 
0.496 
0.492 
0.513 
0.482 
0.495 
0.510 
0.032 
0.048 
0.054 
0.059 
0.067 
0.077 
0.087 
0.095 
0.098 
0.112 
0.151 
0.152 
0.188 
0.201 
0.220 
0.249 
0.310 
0.305 
0.301 
0.343 
0.034 
0.047 
0.052 
0.056 
0.059 
0.071 
0.093 
0.079 
0.078 
0.088 
0.112 
0.103 
0.150 
0.145 
0.170 
0.187 
0.260 
0.247 
0.221 
0.259 
0.035 
0.053 
0.059 
0.064 
0.072 
0.083 
0.095 
0.104 
0.107 
0.123 
0.164 
0.166 
0.205 
0.219 
0.240 
0.272 
0.339 
0.333 
0.329 
0.375 
0.014 
0.022 
0.023 
0.024 
0.027 
0.031 
0.037 
0.041 
0.044 
0.050 
0.065 
0.065 
0.080 
0.086 
0.095 
0.107 
0.135 
0.132 
0.131 
0.149 
0.998 
0.998 
0.998 
0.998 
0.998 
0.998 
0.997 
0.997 
0.995 
0.995 
0.994 
0.994 
0.988 
0.990 
0.984 
0.984 
0.966 
0.966 
0.970 
0.962 
1.000 
0.999 
1.000 
0.999 
1.000 
0.999 
0.999 
0.999 
0.999 
0.999 
0.998 
0.999 
0.997 
0.997 
0.996 
0.996 
0.991 
0.991 
0.992 
0.990 
All reflections 37.1 2.3 2.2 0.547 0.082 0.058 0.089 0.035   
 
 
Shell I/Sigma in resolution shells: 
Lower 
limit 
Upper 
limit 
% of of reflections with I / Sigma less than 
0 1 2 3 5 10 20 >20 total 
50.00 
6.78 
5.38 
4.70 
4.27 
3.97 
3.73 
3.55 
3.39 
3.26 
3.15 
3.05 
2.96 
2.89 
2.82 
2.75 
2.69 
2.64 
2.59 
2.54 
6.78 
5.38 
4.70 
4.27 
3.97 
3.73 
3.55 
3.39 
3.26 
3.15 
3.05 
2.96 
2.89 
2.82 
2.75 
2.69 
2.64 
2.59 
2.54 
2.50 
1.0 
1.0 
0.6 
0.7 
2.4 
4.5 
3.7 
7.0 
6.1 
7.2 
11.1 
9.4 
10.0 
11.0 
10.8 
10.7 
11.5 
10.7 
10.2 
10.5 
1.9 
4.0 
4.1 
3.4 
7.0 
10.6 
10.6 
15.2 
19.6 
21.3 
26.7 
24.8 
27.6 
30.5 
29.0 
32.2 
31.7 
30.6 
28.5 
27.8 
2.7 
6.5 
7.6 
6.5 
11.6 
16.3 
18.6 
23.2 
28.4 
33.5 
37.6 
35.3 
39.4 
41.1 
41.4 
44.0 
42.7 
42.1 
40.0 
39.7 
3.7 
8.9 
10.6 
10.3 
16.3 
20.3 
22.2 
29.5 
35.1 
39.5 
43.9 
42.8 
46.2 
48.4 
49.9 
50.5 
51.8 
48.9 
47.3 
46.3 
4.8 
14.4 
15.6 
15.6 
23.5 
28.7 
30.4 
37.7 
44.6 
48.1 
54.1 
54.1 
56.4 
59.9 
58.8 
60.0 
61.2 
60.2 
56.2 
55.9 
9.4 
25.8 
28.0 
27.5 
37.9 
41.9 
46.2 
53.4 
59.1 
62.3 
71.0 
70.0 
72.9 
73.6 
73.4 
75.5 
75.8 
71.8 
68.8 
67.3 
23.1 
51.7 
52.5 
51.3 
62.0 
64.1 
68.4 
74.8 
78.7 
80.2 
87.4 
86.9 
88.7 
88.5 
87.5 
86.2 
84.8 
80.2 
76.9 
74.1 
76.6 
48.3 
47.5 
48.7 
38.0 
35.9 
31.6 
25.2 
21.3 
19.7 
12.0 
11.0 
7.4 
6.6 
4.6 
3.6 
1.4 
1.3 
1.4 
0.8 
99.7 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
99.9 
99.4 
97.9 
96.2 
95.1 
92.0 
89.7 
86.1 
81.5 
78.3 
74.8 
All hkl 6.9 19.2 27.6 33.3 41.6 55.1 72.0 22.6 94.6 
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Shell Summary of observation redundancies: 
Lower 
limit 
Upper 
limit 
% of reflections with given No. of observations 
0 1 2 3 4 5-6 7-8 9-12 13-19 >19 total 
50.00 
6.78 
5.38 
4.70 
4.27 
3.97 
3.73 
3.55 
3.39 
3.26 
3.15 
3.05 
2.96 
2.89 
2.82 
2.75 
2.69 
2.64 
2.59 
2.54 
6.78 
5.38 
4.70 
4.27 
3.97 
3.73 
3.55 
3.39 
3.26 
3.15 
3.05 
2.96 
2.89 
2.82 
2.75 
2.69 
2.64 
2.59 
2.54 
2.50 
0.3 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.1 
0.6 
2.1 
3.8 
4.9 
8.0 
10.3 
13.9 
18.5 
21.7 
25.2 
0.2 
0.4 
0.1 
0.0 
0.0 
0.1 
0.0 
0.1 
0.5 
0.8 
1.6 
2.1 
2.4 
3.0 
5.2 
5.8 
4.9 
5.6 
4.0 
4.7 
3.0 
3.1 
0.9 
0.9 
0.5 
0.6 
1.1 
0.6 
1.8 
2.2 
3.7 
3.7 
3.5 
3.9 
3.2 
2.3 
2.7 
3.2 
3.2 
2.8 
4.2 
8.3 
4.4 
2.5 
2.0 
2.0 
5.1 
5.2 
5.2 
6.7 
6.7 
5.0 
4.2 
5.8 
5.2 
4.6 
5.1 
3.6 
3.5 
3.8 
20.5 
9.0 
10.0 
9.9 
11.0 
9.0 
5.8 
6.7 
8.5 
7.4 
6.6 
6.7 
7.4 
5.7 
6.6 
6.0 
6.5 
7.4 
6.3 
6.5 
15.2 
36.0 
21.2 
17.8 
12.6 
13.3 
31.3 
36.2 
49.0 
40.5 
24.7 
20.6 
21.1 
22.7 
22.2 
22.2 
21.3 
21.6 
20.2 
20.0 
56.6 
43.2 
63.4 
69.0 
74.0 
74.9 
56.7 
51.1 
35.1 
42.4 
55.9 
59.7 
57.5 
54.0 
49.7 
48.9 
45.6 
40.2 
41.1 
37.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
99.7 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
99.9 
99.4 
97.9 
96.2 
95.1 
92.0 
89.7 
86.1 
81.5 
78.3 
74.8 
All hkl 5.4 2.0 2.3 4.7 8.2 24.4 52.9 0.0 0.0 0.0 94.6 
 
 
Shell  
Average Redundancy Per Shell Lower 
limit 
Upper 
limit 
50.00 
6.78 
5.38 
4.70 
4.27 
3.97 
3.73 
3.55 
3.39 
3.26 
3.15 
3.05 
2.96 
2.89 
2.82 
2.75 
2.69 
2.64 
2.59 
2.54 
6.78 
5.38 
4.70 
4.27 
3.97 
3.73 
3.55 
3.39 
3.26 
3.15 
3.05 
2.96 
2.89 
2.82 
2.75 
2.69 
2.64 
2.59 
2.54 
2.50 
6.3 
5.9 
6.5 
6.7 
6.9 
6.9 
6.4 
6.2 
5.8 
6.0 
6.2 
6.3 
6.2 
6.1 
6.0 
6.0 
6.0 
5.9 
6.0 
5.9 
All hkl 6.2 
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NADH-CPILE-a 
Summary of reflections intensities and R-factors by shells 
     R linear = SUM ( ABS(I - <I>)) / SUM (I) 
     R square = SUM ( (I - <I>) ** 2) / SUM (I ** 2) 
     Chi**2   = SUM ( (I - <I>) ** 2) / (Error ** 2 * N / (N-1) ) ) 
     In all sums single measurements are excluded 
Shell  
limit 
Lower Upper Average Average Norm. Linear Square  
Angstrom I error Stat. Chi**2 R-fac R-fac Rmeas Rpim CC1/2 CC* 
50.00 
6.13 
4.87 
4.25 
3.86 
3.59 
3.38 
3.21 
3.07 
2.95 
2.85 
2.76 
2.68 
2.61 
2.55 
2.49 
2.43 
2.39 
2.34 
2.30 
6.13 
4.87 
4.25 
3.86 
3.59 
3.38 
3.21 
3.07 
2.95 
2.85 
2.76 
2.68 
2.61 
2.55 
2.49 
2.43 
2.39 
2.34 
2.30 
2.26 
2235.9 
1353.9 
1832.8 
1446.0 
1148.1 
943.4 
705.0 
503.4 
398.3 
309.4 
227.6 
193.7 
139.7 
136.5 
118.6 
97.9 
88.0 
80.7 
71.5 
62.9 
33.3 
22.0 
29.4 
25.2 
21.6 
19.4 
16.1 
13.5 
12.1 
11.0 
10.1 
9.7 
9.2 
9.1 
9.0 
8.8 
8.8 
8.8 
8.7 
9.6 
11.6 
11.1 
14.3 
13.3 
12.9 
12.1 
11.3 
10.4 
9.9 
9.5 
9.2 
9.0 
8.8 
8.7 
8.7 
8.6 
8.6 
8.6 
8.5 
9.5 
3.055 
3.593 
3.901 
3.899 
4.044 
4.100 
3.944 
3.621 
3.662 
3.442 
3.093 
3.067 
2.844 
2.925 
2.759 
2.772 
2.634 
2.584 
2.479 
2.429 
0.037 
0.049 
0.052 
0.057 
0.065 
0.069 
0.079 
0.092 
0.103 
0.123 
0.146 
0.170 
0.214 
0.213 
0.235 
0.283 
0.305 
0.318 
0.337 
0.369 
0.040 
0.049 
0.055 
0.056 
0.062 
0.057 
0.065 
0.074 
0.072 
0.092 
0.107 
0.122 
0.164 
0.141 
0.157 
0.203 
0.218 
0.224 
0.237 
0.263 
0.041 
0.054 
0.058 
0.063 
0.071 
0.076 
0.087 
0.101 
0.112 
0.134 
0.160 
0.185 
0.233 
0.232 
0.255 
0.308 
0.332 
0.346 
0.368 
0.408 
0.017 
0.022 
0.024 
0.026 
0.029 
0.032 
0.035 
0.041 
0.045 
0.054 
0.064 
0.073 
0.091 
0.091 
0.100 
0.120 
0.130 
0.136 
0.145 
0.169 
0.999 
0.998 
0.998 
0.997 
0.997 
0.997 
0.997 
0.996 
0.997 
0.994 
0.993 
0.992 
0.986 
0.989 
0.987 
0.978 
0.973 
0.974 
0.973 
0.948 
1.000 
1.000 
0.999 
0.999 
0.999 
0.999 
0.999 
0.999 
0.999 
0.998 
0.998 
0.998 
0.996 
0.997 
0.997 
0.994 
0.993 
0.993 
0.993 
0.986 
All reflections 620.2 15.0 10.3 3.241 0.077 0.054 0.084 0.034   
 
 
Shell I/Sigma in resolution shells: 
Lower 
limit 
Upper 
limit 
% of of reflections with I / Sigma less than 
0 1 2 3 5 10 20 >20 total 
50.00 
6.13 
4.87 
4.25 
3.86 
3.59 
3.38 
3.21 
3.07 
2.95 
2.85 
2.76 
2.68 
2.61 
2.55 
2.49 
2.43 
2.39 
2.34 
2.30 
6.13 
4.87 
4.25 
3.86 
3.59 
3.38 
3.21 
3.07 
2.95 
2.85 
2.76 
2.68 
2.61 
2.55 
2.49 
2.43 
2.39 
2.34 
2.30 
2.26 
0.8 
1.8 
1.0 
2.5 
2.8 
2.3 
2.1 
2.3 
3.0 
3.3 
3.0 
3.7 
4.1 
4.7 
4.7 
4.3 
6.7 
4.6 
7.6 
9.5 
1.4 
2.2 
1.2 
3.2 
3.9 
3.8 
3.9 
4.6 
5.4 
6.1 
6.4 
7.7 
8.4 
10.2 
10.5 
11.8 
13.8 
12.8 
16.7 
20.1 
1.7 
3.0 
2.4 
4.2 
5.1 
5.2 
5.2 
8.5 
7.8 
9.2 
10.6 
14.6 
15.2 
17.9 
17.6 
19.8 
22.8 
23.5 
29.7 
33.9 
1.9 
4.1 
3.3 
5.3 
6.2 
6.6 
7.8 
11.8 
11.2 
13.2 
15.7 
19.5 
23.2 
24.9 
26.6 
28.9 
32.6 
34.1 
40.2 
43.8 
2.5 
5.4 
4.6 
6.9 
8.8 
8.7 
11.5 
17.7 
16.4 
18.4 
25.4 
28.1 
34.6 
36.5 
39.8 
44.7 
47.3 
51.4 
54.6 
59.4 
4.7 
9.5 
7.7 
12.4 
13.6 
16.2 
21.9 
26.9 
27.1 
34.0 
41.5 
46.3 
56.6 
55.8 
60.9 
65.6 
68.5 
71.3 
74.9 
76.1 
8.6 
17.2 
13.8 
21.0 
25.4 
28.0 
37.2 
43.3 
49.9 
54.8 
63.7 
66.7 
74.8 
76.4 
80.1 
81.8 
84.8 
87.1 
87.9 
88.1 
87.3 
82.7 
85.6 
78.6 
74.0 
71.4 
62.2 
55.7 
49.1 
44.3 
34.6 
32.4 
23.9 
21.6 
17.9 
16.0 
13.2 
11.1 
9.7 
6.9 
95.9 
99.9 
99.5 
99.5 
99.4 
99.3 
99.4 
99.0 
99.0 
99.1 
98.3 
99.1 
98.7 
98.0 
98.0 
97.8 
98.0 
98.1 
97.6 
95.0 
All hkl 3.7 7.6 12.7 17.8 25.8 39.1 54.0 44.4 98.4 
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Shell Summary of observation redundancies: 
Lower 
limit 
Upper 
limit 
% of reflections with given No. of observations 
0 1 2 3 4 5-6 7-8 9-12 13-19 >19 total 
50.00 
6.13 
4.87 
4.25 
3.86 
3.59 
3.38 
3.21 
3.07 
2.95 
2.85 
2.76 
2.68 
2.61 
2.55 
2.49 
2.43 
2.39 
2.34 
2.30 
6.13 
4.87 
4.25 
3.86 
3.59 
3.38 
3.21 
3.07 
2.95 
2.85 
2.76 
2.68 
2.61 
2.55 
2.49 
2.43 
2.39 
2.34 
2.30 
2.26 
4.1 
0.1 
0.5 
0.5 
0.6 
0.7 
0.6 
1.0 
1.0 
0.9 
1.7 
0.9 
1.3 
2.0 
2.0 
2.2 
2.0 
1.9 
2.4 
5.0 
1.2 
0.9 
1.1 
0.6 
0.9 
0.8 
0.9 
1.4 
1.2 
0.9 
0.7 
0.9 
1.3 
0.8 
0.9 
0.8 
1.8 
1.5 
1.1 
3.3 
3.9 
2.4 
2.6 
3.6 
3.0 
3.4 
3.2 
3.3 
2.4 
3.4 
3.2 
3.0 
2.9 
2.5 
2.4 
2.9 
2.6 
3.0 
2.6 
6.5 
5.7 
6.2 
6.4 
7.8 
7.7 
7.3 
6.2 
5.4 
5.7 
6.0 
5.1 
4.6 
5.6 
5.5 
5.0 
4.5 
3.8 
5.5 
4.5 
10.5 
22.9 
18.8 
19.0 
17.7 
20.0 
18.3 
15.7 
14.0 
14.3 
11.2 
10.6 
10.9 
8.1 
8.3 
8.8 
7.3 
7.6 
8.0 
8.5 
12.1 
24.1 
24.1 
23.4 
24.6 
24.4 
26.3 
27.2 
26.5 
25.7 
23.7 
26.0 
25.1 
25.1 
23.3 
24.2 
26.6 
24.6 
25.0 
30.6 
26.4 
38.2 
47.6 
46.9 
45.2 
43.3 
43.2 
46.2 
48.3 
49.7 
53.9 
52.8 
54.5 
55.6 
57.6 
56.8 
55.8 
57.7 
55.2 
50.2 
36.2 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
95.9 
99.9 
99.5 
99.5 
99.4 
99.3 
99.4 
99.0 
99.0 
99.1 
98.3 
99.1 
98.7 
98.0 
98.0 
97.8 
98.0 
98.1 
97.6 
95.0 
All hkl 1.6 1.2 3.1 5.9 13.2 25.3 49.7 0.0 0.0 0.0 98.4 
 
 
Shell  
Average Redundancy Per Shell Lower 
limit 
Upper 
limit 
50.00 
6.13 
4.87 
4.25 
3.86 
3.59 
3.38 
3.21 
3.07 
2.95 
2.85 
2.76 
2.68 
2.61 
2.55 
2.49 
2.43 
2.39 
2.34 
2.30 
6.13 
4.87 
4.25 
3.86 
3.59 
3.38 
3.21 
3.07 
2.95 
2.85 
2.76 
2.68 
2.61 
2.55 
2.49 
2.43 
2.39 
2.34 
2.30 
2.26 
5.6 
5.9 
5.9 
5.8 
5.8 
5.8 
5.9 
6.0 
6.0 
6.1 
6.2 
6.2 
6.3 
6.3 
6.3 
6.3 
6.3 
6.2 
6.2 
5.4 
All hkl 6.0 
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E49R CPILE-a 
Summary of reflections intensities and R-factors by shells 
     R linear = SUM ( ABS(I - <I>)) / SUM (I) 
     R square = SUM ( (I - <I>) ** 2) / SUM (I ** 2) 
     Chi**2   = SUM ( (I - <I>) ** 2) / (Error ** 2 * N / (N-1) ) ) 
     In all sums single measurements are excluded 
 
Shell  
limit 
Lower Upper Average Average Norm. Linear Square  
Angstrom I error Stat. Chi**2 R-fac R-fac Rmeas Rpim CC1/2 CC* 
50.00 
5.16 
4.09 
3.58 
3.25 
3.02 
2.84 
2.70 
2.58 
2.48 
2.39 
2.32 
2.25 
2.19 
2.14 
2.09 
2.05 
2.01 
1.97 
1.93 
5.16 
4.09 
3.58 
3.25 
3.02 
2.84 
2.70 
2.58 
2.48 
2.39 
2.32 
2.25 
2.19 
2.14 
2.09 
2.05 
2.01 
1.97 
1.93 
1.90 
269.0 
236.8 
173.8 
119.6 
74.8 
47.5 
32.5 
22.8 
19.6 
15.7 
13.8 
12.0 
11.0 
8.6 
7.3 
6.3 
4.8 
4.0 
3.4 
3.2 
6.9 
6.6 
5.5 
4.6 
3.5 
2.9 
2.7 
2.6 
2.8 
2.9 
3.0 
3.0 
3.0 
3.0 
3.0 
3.1 
3.2 
3.4 
3.7 
3.9 
5.8 
5.8 
4.9 
4.2 
3.3 
2.8 
2.6 
2.6 
2.8 
2.9 
3.0 
3.0 
3.0 
3.0 
3.0 
3.1 
3.2 
3.4 
3.7 
3.9 
1.499 
1.126 
1.290 
1.360 
1.173 
1.073 
0.978 
0.911 
0.821 
0.794 
0.781 
0.762 
0.670 
0.620 
0.590 
0.630 
0.507 
0.494 
0.510 
0.626 
0.054 
0.055 
0.066 
0.079 
0.095 
0.122 
0.158 
0.208 
0.227 
0.277 
0.317 
0.379 
0.401 
0.488 
0.552 
0.606 
0.705 
0.777 
0.868 
0.803 
0.059 
0.060 
0.071 
0.080 
0.091 
0.112 
0.145 
0.191 
0.200 
0.250 
0.282 
0.350 
0.339 
0.409 
0.464 
0.557 
0.537 
0.593 
0.609 
0.632 
0.059 
0.060 
0.072 
0.087 
0.103 
0.132 
0.171 
0.225 
0.247 
0.303 
0.346 
0.413 
0.437 
0.534 
0.606 
0.671 
0.790 
0.880 
1.002 
0.939 
0.023 
0.023 
0.028 
0.035 
0.040 
0.051 
0.065 
0.085 
0.096 
0.119 
0.139 
0.162 
0.172 
0.213 
0.247 
0.282 
0.346 
0.401 
0.485 
0.474 
0.998 
0.997 
0.997 
0.997 
0.995 
0.993 
0.990 
0.984 
0.977 
0.964 
0.960 
0.950 
0.945 
0.923 
0.907 
0.881 
0.841 
0.784 
0.678 
0.799 
1.000 
0.999 
0.999 
0.999 
0.999 
0.998 
0.997 
0.996 
0.994 
0.991 
0.990 
0.987 
0.986 
0.980 
0.975 
0.968 
0.956 
0.937 
0.899 
0.942 
All reflections 56.8 3.7 3.5 0.902 0.104 0.070 0.113 0.045   
 
 
Shell I/Sigma in resolution shells: 
Lower 
limit 
Upper 
limit 
% of of reflections with I / Sigma less than 
0 1 2 3 5 10 20 >20 total 
50.00 
5.16 
4.09 
3.58 
3.25 
3.02 
2.84 
2.70 
2.58 
2.48 
2.39 
2.32 
2.25 
2.19 
2.14 
2.09 
2.05 
2.01 
1.97 
1.93 
5.16 
4.09 
3.58 
3.25 
3.02 
2.84 
2.70 
2.58 
2.48 
2.39 
2.32 
2.25 
2.19 
2.14 
2.09 
2.05 
2.01 
1.97 
1.93 
1.90 
0.7 
0.3 
1.1 
1.4 
1.4 
2.9 
2.2 
4.3 
4.6 
6.1 
7.2 
8.7 
8.7 
11.8 
13.6 
17.0 
18.1 
21.3 
26.4 
19.5 
1.9 
1.6 
2.4 
3.8 
4.8 
7.3 
8.4 
13.1 
16.0 
20.1 
23.1 
26.2 
29.8 
35.9 
42.6 
46.7 
52.7 
57.6 
60.2 
46.8 
3.5 
3.4 
3.7 
6.3 
8.9 
12.3 
17.0 
24.2 
28.6 
34.2 
40.1 
44.3 
49.5 
57.0 
61.3 
67.4 
73.0 
76.8 
77.0 
61.2 
4.4 
4.6 
6.2 
9.3 
12.5 
17.1 
25.2 
33.9 
39.2 
45.8 
51.1 
56.1 
61.1 
67.7 
72.5 
77.5 
82.3 
84.7 
83.5 
66.7 
5.7 
7.3 
10.0 
13.9 
19.2 
26.5 
36.4 
48.1 
53.9 
61.7 
67.0 
70.9 
75.1 
79.6 
82.9 
86.4 
90.5 
91.9 
88.1 
70.5 
10.9 
13.7 
18.1 
24.6 
35.2 
46.1 
58.4 
68.7 
74.5 
80.2 
84.0 
87.4 
88.5 
93.2 
94.4 
96.3 
97.1 
96.6 
91.6 
72.5 
25.4 
29.3 
37.0 
47.9 
60.9 
72.8 
82.8 
89.6 
92.2 
95.2 
97.1 
97.7 
98.5 
99.4 
99.6 
99.3 
98.4 
97.5 
92.1 
72.8 
74.1 
70.6 
63.0 
52.1 
39.1 
27.2 
17.2 
10.4 
7.8 
4.8 
2.9 
2.2 
1.5 
0.6 
0.1 
0.1 
0.0 
0.0 
0.0 
0.0 
99.6 
99.9 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
99.9 
100.0 
100.0 
99.6 
99.4 
98.4 
97.5 
92.1 
72.8 
All hkl 8.8 24.8 37.1 44.6 53.8 66.1 78.9 19.1 98.0 
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Shell Summary of observation redundancies: 
Lower 
limit 
Upper 
limit 
% of reflections with given No. of observations 
0 1 2 3 4 5-6 7-8 9-12 13-19 >19 total 
50.00 
5.16 
4.09 
3.58 
3.25 
3.02 
2.84 
2.70 
2.58 
2.48 
2.39 
2.32 
2.25 
2.19 
2.14 
2.09 
2.05 
2.01 
1.97 
1.93 
5.16 
4.09 
3.58 
3.25 
3.02 
2.84 
2.70 
2.58 
2.48 
2.39 
2.32 
2.25 
2.19 
2.14 
2.09 
2.05 
2.01 
1.97 
1.93 
1.90 
0.4 
0.1 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.1 
0.0 
0.0 
0.4 
0.6 
1.6 
2.5 
7.9 
27.2 
0.4 
0.5 
0.3 
0.3 
0.1 
0.0 
0.2 
0.1 
0.2 
0.2 
0.2 
0.4 
0.3 
0.1 
0.4 
1.6 
2.1 
5.6 
9.9 
13.2 
5.4 
1.6 
2.7 
3.6 
2.0 
1.3 
1.2 
1.4 
2.9 
3.7 
3.6 
2.3 
2.6 
2.4 
3.1 
6.8 
9.0 
14.0 
16.1 
14.1 
3.4 
2.1 
2.3 
2.7 
1.6 
1.8 
1.1 
1.3 
1.8 
1.6 
3.4 
3.0 
2.5 
3.2 
4.8 
8.1 
13.0 
15.0 
16.9 
11.7 
18.9 
12.8 
10.9 
13.8 
11.3 
10.1 
9.4 
8.9 
10.6 
10.7 
10.9 
9.4 
10.2 
11.8 
15.8 
19.5 
21.5 
22.1 
21.9 
17.6 
26.8 
19.6 
27.8 
39.7 
28.4 
22.9 
18.3 
16.0 
29.0 
34.4 
40.4 
30.6 
31.6 
36.2 
36.7 
32.0 
30.1 
24.0 
18.4 
14.3 
44.7 
63.3 
55.9 
40.0 
56.6 
63.9 
69.8 
72.4 
55.5 
49.3 
41.5 
54.3 
52.8 
46.3 
38.9 
31.4 
22.7 
16.7 
8.9 
2.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
0.0 
99.6 
99.9 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
99.9 
100.0 
100.0 
99.6 
99.4 
98.4 
97.5 
92.1 
72.8 
All hkl 2.0 1.8 5.0 5.0 13.9 27.8 44.5 0.0 0.0 0.0 98.0 
 
 
Shell  
Average Redundancy Per Shell Lower 
limit 
Upper 
limit 
50.00 
5.16 
4.09 
3.58 
3.25 
3.02 
2.84 
2.70 
2.58 
2.48 
2.39 
2.32 
2.25 
2.19 
2.14 
2.09 
2.05 
2.01 
1.97 
1.93 
5.16 
4.09 
3.58 
3.25 
3.02 
2.84 
2.70 
2.58 
2.48 
2.39 
2.32 
2.25 
2.19 
2.14 
2.09 
2.05 
2.01 
1.97 
1.93 
1.90 
6.0 
6.7 
6.5 
6.0 
6.5 
6.7 
6.8 
6.9 
6.4 
6.3 
6.1 
6.4 
6.4 
6.2 
5.9 
5.4 
4.9 
4.4 
3.8 
3.3 
All hkl 5.9 
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